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Abstract 
GENETIC ANALYSIS OF MACULAR TELANGIECTASIA 
NANCY LYNN PARMALEE 
 
Macular telangiectasia type 2, or MacTel, is an adult onset retinal disease that causes 
progressive loss of central vision, usually beginning between the 5th and 7th decades of life. 
Macular degenerative diseases comprise a large portion of the blinding diseases affecting 
people over the age of 50. The collective burden of vision loss and low vision includes the 
impact on patients in loss of independence and decline of self-reported quality of life, as well as 
significant resource allocation in medical and supportive care. There are no cures for macular 
diseases; currently available treatments may slow the progression in some cases, but patients 
remain at risk of losing their eyesight and the independence that vision affords. While macular 
telangiectasia is not as prevalent as other macular degenerative diseases, such as age-related 
macular degeneration, elucidating the causes of MacTel may reveal mechanisms that are 
common to other macular diseases, providing clues to guide research into possible treatment 
targets. 
 
In this work, I have assembled the first cohort of MacTel patients and their family members in 
collaboration with the MacTel Project, an international consortium of researchers and clinicians 
dedicated to studying this disease. I have identified and analyzed families with multiple affected 
relatives in which MacTel appears to be an inherited disease. The goal of this work has been to 
identify a genetic cause for the disease in these families.  To that end, I used genotyping data 
from approximately 900,000 single nucleotide polymorphism per individual to create sets of 
genetic markers for linkage analysis. I analyzed these markers using two-point and multipoint 
linkage algorithms to search for a region of the genome that was inherited in conjunction with 
the phenotype more often than would be expected by chance alone, with the goal of finding a 
causative genetic variant. This analysis resulted in the identification of a region of chromosome 
1 spanning approximately 15 million bases that is significantly linked to the MacTel phenotype. 
 
I analyzed recombination breakpoints in this region, as well as across the genome, to map 
chromosomal segments inherited identical by descent in siblings that express the MacTel 
phenotype. This approach provided a profile for each set of siblings of regions of the genome 
incompatible with inherited genetic disease by virtue of the fact that no alleles were shared 
identical by descent. I then compared these regions across families under the hypothesis that if 
MacTel is caused by the same gene in all families, the chromosomal region harboring a 
causative variant would fail to be excluded in any family.  This analysis excluded much of the 
genome and refined the boundaries of the linkage interval on chromosome 1, but did not 
appreciably narrow the region of interest.  
 
In parallel with analysis of linkage in families, I sequenced 40 genes of interest as possible 
functional candidates, using Sanger sequencing in the probands of families with multiple 
affected relatives. I selected candidate genes based on gene function and expression, choosing 
genes with a plausible connection to the phenotype based on information in the literature. 
Thirteen of these genes were selected based on their location in the region of the maximum 
linkage score. I was unable to identify any variant that was consistent with being a causative 
variant for inherited MacTel. 
 
I performed a broader search using exome sequencing to investigate all protein coding regions 
in the genome in four affected individuals—two affected sisters, and two unrelated family 
probands. The goal of this effort was to identify a gene with rare or unknown missense variants 
in all four of the affected individuals. The expectation was that a causative variant would be 
inherited identical by descent in the affected sisters, and either the same variant, or a different 
variant in the same gene would be present in the unrelated probands. At the time this 
experiment was performed, exome sequencing had only just become broadly available to 
researchers, and, as I learned, was not free of technical limitations. The data failed to provide 
adequate coverage of the exome to evaluate the intended hypothesis, but did provide useful 
lessons in the promise and the hazards of high throughput sequencing, which I will discuss in 
detail. 
 
In summary, this work represents the first in depth genetic analysis of a cohort of MacTel 
families with inherited disease. I have identified a region of chromosome 1 linked to the 
disease, providing the first evidence for a MacTel susceptibility locus. This work is ongoing, in 
the hopes of identifying a causative gene for MacTel that will shed light on the underlying 
mechanism of the disease, and potentially guide the effort to develop effective treatments for 
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CHAPTER ONE –  INTRODUCTION  
 
MACULAR TELANGIECTASI A TYPE 2  AND THE MACTEL PROJECT  
  
It is estimated that in 2002, more than 161 million people in the world suffered from visual 
impairment. At least 37 million people were blind, with the greatest proportion of cases of 
blindness occurring in people over age 50 (Resnikoff et al., 2004). Age-related macular 
degeneration (AMD) is the third leading cause of blindness in the world, and the primary cause 
of blindness in developed countries; the primary risk factor for blindness or low vision is 
considered to be aging. The World Health Organization estimates that more than 82% of all 
those who are blind are over age 50 (http://www.vision2020.org/main.cfm?type=FACTS). As 
global demographics shift, an increasingly greater segment of the population is at risk for losing 
functional vision. Research efforts to define the pathology of AMD and other macular 
degenerative disorders have intensified accordingly, and much progress has been made. 
However, much work remains to be done. The work described in this thesis investigates a 
comparatively rare macular degenerative disease, macular telangiectasia type 2, or MacTel. 
Patients usually present with complaints of visual distortion between the ages of 50 and 70. 
Frequently, the onset is slow and progressive, with some patients reporting that they first 
noticed changes in their vision many years before seeking treatment. While the burden of 
MacTel is far lower than that of more prevalent diseases, the impact on those who are affected 
is significant. Although MacTel is not considered a blinding disorder, the disease disrupts the 
delicate architecture of the macula and the fovea—the regions of the retina that provide the 
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high-resolution central vision needed for tasks such as reading and driving—causing 
considerable disruption to vision.  As with many less prevalent diseases, MacTel had not been 
the focus of intense research efforts, given that it was thought to be very rare. One can imagine 
that patients who received a diagnosis of MacTel were confronted not only with the 
progressive loss of visual acuity that is the hallmark of the disease, but also with a lack of 
treatment options, and uncertainty about how the disease would progress and whether their 
children were likely to be at increased risk. 
 
From the clinician’s standpoint, retinal specialists who diagnose and treat MacTel patients have 
persistently expressed the view that MacTel has been underdiagnosed. The early signs of the 
disease are subtle changes in the distribution of pigment in the retina that are only detectable 
with specialized imaging, thus, many cases may be missed when this imaging is unavailable or is 
not routinely performed. In the late stages of the disease, the architecture of the retina can be 
profoundly disrupted, such that the key diagnostic signs can no longer be distinguished. These 
cases may be misdiagnosed as AMD, which also profoundly disrupts the organization of the 
retina. 
 
The MacTel Project (established in 2005, with funding from the Lowy Medical Research 
Foundation) is an international consortium of clinicians and basic science researchers working 
toward understanding the pathogenesis and progression of MacTel, with the goal of eventually 
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translating basic science findings into treatment targets. The work contained in this thesis has 
been performed under the auspices of the MacTel Project. 
 
Many insights into the molecular mechanisms of disease pathologies have been achieved by the 
discovery of genetic variants in rare diseases. The hope is that insights into the mechanism of 
pathology in MacTel could be extended to other diseases of the retina. The most prominent 
features of the MacTel phenotype are aberrant macular pigment distribution, and changes in 
the retinal vasculature. Macular pigments protect the retina from damaging short wavelength 
light, however the molecular pathways responsible for transporting and depositing pigments in 
the retina are still very poorly understood. Macular pigment is thought to play an important 
role in AMD pathogenicity (Loane et al., 2008a; Loane et al., 2008b), thus, learning more about 
the mechanisms of macular pigment transport through the study of the etiology of MacTel 
could yield important information to inform research efforts in AMD and other diseases. 
Similarly, dysregulation of retinal vessels is the catastrophic event in the progression of many 
retinal diseases, including AMD, diabetic retinopathy, retinopathy of prematurity, and a 
proportion of glaucoma cases (Rajappa et al., 2010).  
 
In the following sections, I will describe the architecture of the retina to lay the groundwork for 
a detailed description of the MacTel phenotype. I will discuss the evidence that led to the 
hypothesis of MacTel as an inherited disease, and the important discovery of familial cases of 
MacTel, which shaped the rest of the project. Finally, I will introduce the research approaches I 
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have pursued during the course of this work, the reasoning behind the choice of methods, and 
both the positive and negative results achieved through these methods. 
THE ARCHITECTURE OF THE R ETI NA  
 
In humans, the retina (Figure 1) develops before birth, as an outgrowth of the central nervous 
system. The neural retina contains six main types of cells: ganglion, amacrine, horizontal, 
bipolar, Mueller glia, and photoreceptors (Dowling, 1987). Each of these cell types has 
specialized subtypes. The retina is highly organized, with stereotyped patterning of cell types 
located in distinct regions (Figure 2). The most superficial cell layer (closest to the front of the 
eye) is the ganglion cell layer. Deep to that are the amacrine, bipolar, and horizontal cells. The 
Mueller glia cells extend from the outer nuclear layer to the vitreal face of the retina. The 
photoreceptors are located at the deepest layer. The inner limiting membrane separates the 
neural retina from the vitreous fluid that occupies most of the volume of the eye. The inner 
plexiform layer lies deep to the ganglion cell layer, and contains the synapses between 
ganglion, bipolar, amacrine, and horizontal cells. The inner nuclear layer consists of the cell 
bodies of amacrine, horizonal, and bipolar cells. The outer plexiform layer contains the 
projections of the photoreceptor cells that synapse with bipolar cells. The outer nuclear layer 
contains the nuclei of the photoreceptors, and the outer segment consists of the light 
responsive portion of the photoreceptors. The outer limiting membrane separates the outer 
segment of the photoreceptors from their nuclei. Additionally, the retinal pigment epithelium 
(RPE), which is not a part of the neural retina, lines the back of the retina and provides support 




Figure 1. Anatomy of the eye. (Left) Overview of the eye. Light passes through the cornea, 
pupil, lens, and vitreous gel to reach the retina at the back of the eye, where photoreceptors 
are activated. (Right) Color fundus photograph of a normal retina. The optic disk, where the 
optic nerve reaches the eye, is seen as a light colored half circle on the leftmost edge of the 
image. Blood vessels extend from the optic disk to the periphery of the retina. The inner circle 
designates the fovea; the region between the the two concentric circles is the parafovea. The 
fovea and the parafovea lie within the macula,  shown as the region within the oval (Photo 
credits: National Eye Institute). 
 
The adult retina is supplied by two vascular systems: the choroid, which lies deep to the RPE, 
and the retinal vasculature, which is organized in an arcade of three layers, the first at the 
ganglion cell layer, and the second and third at the superficial and deep boundaries of the inner 





Figure 2. Vertical section of the human retina. The deepest layers (back of the eye) are at the 
top of the image, the superficial layers, at the bottom. (Image courtesy of Bryan William Jones, 
Ph.D.  Marc Laboratory, Moran Eye Center. Used with permission.) 
 
The macula is a specialized structure of the retina, found in only a few species, including 
primates (Finlay, 2008). At the center of the macula, is the fovea, surrounded by the parafovea. 
The fovea contains a dense concentration of  cone photoreceptors, which provide a high degree 
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of central visual acuity. Disruption in this region compromises high-resolution vision, and can 
significantly impair the ability to perform activities such as reading and driving. The macular 
pigments lutein and zeathanthin are localized in the fovea and parafovea; zeathanthin is found 
primarily in the fovea, and lutein is found primarily in the parafovea (Loane et al., 2008b). 
Lutein and zeathanthin are dietary xanthophyll carotenoids. They are not synthesized 
physiologically, and must be obtained through the diet, converted to a biologically available 
form, and transported to the retina. The molecular mechanisms for their transport and 
deposition are poorly understood. One binding protein for zeathanthin, GSTP1, has been 
identified (Bhosale et al., 2004; Loane et al., 2008b), however the binding protein for lutein 
remains unknown.  
 
THE MACTEL PHENOTYPE  
 
Macular telangiectasia is also known as idiopathic juxtafoveal telangiectasia. The term 
idiopathic indicates that the cause of the disease is unknown. The first signs of disease are 
noted in the region adjacent to the fovea, termed the juxtafoveal region. The fovea is the part 
of the retina most critically responsible for functional, high-resolution vision. The term 
telangiectasia refers to blood vessels that are dilated, with irregular appearance.  
 
Patients with MacTel generally experience a gradual decline in visual function, often with 
distortions in the visual field, known as metamorphopsia (Figure 3). Patients may experience a 
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scotoma, or blind spot, that can be very disruptive to activities that require attention at the 
center of the visual field. On examination, early signs of MacTel include changes in the 
transparency and reflectivity of the retina, especially with hyperreflective spots in the deep 
layers of the retina, depletion of the macular pigments, lutein and zeathanthin, that protect the 
retina from light damage, macular edema, macular holes, and dilated and tortuous blood 
vessels, often with capillary leakage. In advanced cases the blood vessels in the retina may 
become neovascular, with aberrant vessel growth invading the inner nuclear layer and 
disrupting the architecture of the retina. Right angle venules are frequently observed as a result 
of vascular dysregulation. These are vessels that do not exhibit a normal branching pattern, but 
rather sprout at a right angle to the vessel of origin. Vessels that extend toward the macula, 
which is avascular in the absence of disease, can disrupt the organization of the retina, resulting 
in vision loss. Atrophy of the macula occurs in the most progressed cases, with presumed loss of 
photoreceptors.  
 
Figure 3. The Amsler grid (left) is a diagnostic tool used to screen for visual distortions, 
especially of the type experienced with macular disease. When viewed with one eye at a time, 
focusing on the center square, the lines should appear parallel, with no missing spaces. The 
right panel shows the way the Amsler grid might look to a patient with macular disease (Image 
credit: National Eye Institute).  
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The term telangiectasia is used to describe blood vessels that are dilated and tortuous. Normal 
vessels have an orderly appearance, tracing a smooth line, with few twists and turns. 
Telangiectatic vessels are erratic and wandering, with many twists, irregular vessel diameter, 
and a general loss of stereotyped patterning.  Telangiectasias can occur systemically, as in 
ataxia telangiectasia, a neurodegenerative disorder, or locally, as in varicose veins. One of the 
most readily observable aspects of the MacTel phenotype is retinal telangiectasia. Severe 
telangiectasia is visible on color photographs of the retina, and by direct observation during an 
ophthalmic examination. Less pronounced disturbances can be observed with fluorescein 
angiography, in which a fluorescent dye is injected to image the retinal vessels.  Gass and Blodi 
classified the retinal telangiectasias in 1993 (Gass and Blodi, 1993). Type 1, or aneurismal 
telangiectasia, is generally unilateral, and is most commonly seen in men. Type 2, MacTel, is 
generally bilateral, and affects both men and women. Type 3, occlusive telangiectasia, is 
extremely rare. Yannuzzi et. al. reclassified the disorders in 2006 (Yannuzzi et al., 2006), 
expanding on the clinical definitions with improved imaging techniques. This seminal 
publication emphasizes that while telangiectasia is the most prominent feature of each of these 
pathologies, it is not necessarily the first sign of the disease in the case of MacTel. The use of 
the term “telangiectasia” in naming the pathology may turn out to be a misnomer when the 
phenotype is more fully characterized; a vascular response to any perturbation is recognized 
among clinicians to be a stereotyped response to metabolic perturbations in the retina. 
Nonetheless, intraretinal neovascularization involves a specific tissue response, and thus, this 
aspect of the phenotype may yet prove to be informative in understanding the mechanism of 
the disease.  
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MacTel is characterized by changes in the transparency and reflectivity of the retina, due to 
changes in the distribution of the macular pigments, lutein and zeathanthin. Yannuzi noted that 
these changes are observed in MacTel patients without retinal aberrations, and proposed that 
macular pigment changes are likely primary to vascular dysregulation. Recent work by groups in 
the MacTel Project has expanded the ability to measure macular pigment and detected that a 
change in macular pigment distribution is one of the earliest signs observed in the disease (Helb 
et al., 2008). Work by Frank Holz,  Peter Charbel-Issa, and Hendrik Scholl, collaborators in the 
MacTel project, has served to expand the technical capacity to capture imagery of the 
distribution of pigment in the macula (Charbel Issa et al., 2009a), helping to better describe the 
MacTel phonotype, and contributing to the overall understanding of the mechanism of macular 
pigment distribution. This work confirms that dysregulation of macular pigment deposition is 
detectable prior to, and in the absence of retinal vascular aberrations in MacTel patients.  
 
While macular pigment distribution appears to be the more proximal facet of the MacTel 
phenotype, the specificity of the vascular aspect of the phenotype remains suggestive. Whether 
vascular effects have a primary mechanistic role in MacTel or not, there may be an underlying 
genetic predisposition that regulates the vascular response. If such a predisposition could be 
discovered, the findings might be extended to other diseases.  Patients with late stages of 
MacTel exhibit vascular abnormalities in addition to telangiectasia. The highly ordered structure 
of the retina is relatively intolerant to disruption, both architecturally, and metabolically. 
Dysregulation of metabolic function resulting in hypoxia can lead to neovacularization (Arjamaa 
and Nikinmaa, 2006).  The patterning of the embryonic retina occurs before birth in humans, 
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and is complete at the end of gestation (Fulton et al., 2009). Subsequent vessel growth, 
referred to as neovascularization, results in improperly patterned, and often leaky vessels. 
Physical disruption of the layers of the retina as a result of vessel growth, or hemorrhage from 
leaky vessels, can be devastating to vision. Most retinal disease involving neovascularization 
involves aberrant vessels arising from the choroid.  Neovascularization arising from the 
intraretinal layer is less common, but has a significant impact in diabetic retinopathy, a subset 
of AMD cases, and is noted significantly in congenital blinding disorders (Fulton et al., 2009). 
The mechanism of the patterning and regulation of the intraretinal vessels remains somewhat 
obscure.  It is significant that in MacTel, neovascularization arises from the intraretinal vessels, 
implying a different mechanism than that of choroidal neovascularization. While it appears that 
changes in macular pigment distribution precede vascular changes in MacTel, it is unknown 
whether dysregulation of the retinal vessels occurs only as a response to earlier events, 
whether a common system impinges on both macular pigment transport and vascular 
regulation, or whether genetic defects in both systems are required for the manifestation of 
both sets of symptoms.  
 
Patients in early stages of the disease may exhibit signs of aberrant macular pigment 
distribution but not vascular defects. As the patients in the cohort are followed, it will likely 
become clear what proportion of cases advance to become more severe over time. Given that 
distinct molecular pathways are responsible for choroidal versus intraretinal vessel formation, it 
is likely that in MacTel, and in other neovascular diseases, an underlying genetic disposition 
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may be responsible for intraretinal vascularization, even if it is a response to disease conditions 
rather than a proximal phenotype. 
 
THE HYPOTHESIS OF MACTEL AS AN INHERITED DISEASE  
 
Indications that MacTel may be, at least in part, a genetic disease came from case reports of 
affected pairs of siblings, and concordant monozygotic twins (Hutton et al., 1978; Chew et al., 
1986; Oh and Park, 1999; Menchini et al., 2000; Siddiqui and Fekrat, 2005; Hannan et al., 2007; 
Gillies et al., 2009). Given the perceived rarity of the disease, the discovery of families with 
multiple affected relatives suggested there could be a genetic component to the etiology of 
MacTel.  However no systematic investigation of the incidence of the disease had been made. 
While anecdotal cases were reported of affected sibling pairs, it was unknown whether the 
relatives of MacTel probands had subclinical signs of the disease. Given that the early stages of 
the phenotype are subtle, and visual disturbances can manifest progressively over the course of 
many years, the hypothesis was made that more familial MacTel cases might be detected by 




Macular telangiectasia is a relatively rare retinal disease as compared to diseases such as AMD 
and glaucoma that have a very high societal burden. However, genetic dissection of this disease 
has the potential to elucidate aspects of macular pigment transport and retinal vascular 
regulation that are relevant to a number of retinal diseases that collectively pose an enormous 
  
13 
burden both on patients, and to society. In conjunction with the MacTel project, we have 
assembled a cohort of over 500 MacTel patients, and the first collection of MacTel families with 
multiple affected relatives. My analysis has consisted of candidate gene screening in the 
probands of multiplex families, linkage analysis in families, and whole exome sequencing in 
selected patients. This work has resulted in the identification of a region on chromosome 1 that 
shows statistically significant evidence of cosegregation with the MacTel phenotype in a subset 
of our families. The chapters that follow will discuss the details of each aspect of this work, the 
conclusions that can be drawn from amassed data from each inquiry, and the next steps in the 




CHAPTER TWO -  DESCRIPTION OF SAMPLE AND INTRODUCTION TO 
GENETIC METHODS  
 
RECRUITMENT OF MACTEL PATIENTS AND RELA TIVES  
 
The MacTel study cohort was ascertained at 23 enrollment centers in seven countries: 
Australia, The United Kingdom, France, Germany, Switzerland, Israel, and the United States. 
Informed consent was obtained at each site in accordance with the Declaration of Helsinki. 
Enrollment protocols were centrally managed by the EMMES Corporation, in Rockville, 
Maryland. MacTel patients, and, whenever possible, relatives of the proband were given a full 
ophthalmic examination. Retinal images were taken and transmitted to the Reading Center at 
Moorfields Eye Hospital, in London. Imaging techniques consisted of color fundus photography, 
autofluorescent angiography, blue light reflectance imaging, and optical coherence 
tomography. Peripheral blood was obtained by venipuncture and sent to the Genetics Center at 
Columbia University. As of April 2011, 1,004 individuals had been enrolled in the genetics 
portion of the study. Of those, 480 were unrelated MacTel patients, 429 were relatives, and 95 
were unrelated controls with no sign of the disease (Table 1a). Controls were recruited at the 
MacTel enrollment centers, usually as a spouse or other unrelated individual attending the 
clinic visit with the proband. 
 
Relatives of 195 MacTel probands were enrolled and screened. In 114 families, 1 relative was 
screened in addition to the proband, in 37 families 2 relatives were screened, and in 44 families 
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three or more relatives were screened. The largest families were family 8, family 21, and family 
156 with 12, 13, and 16 relatives screened respectively (Table 1b). The number of relatives 
screened was dependent on the size of the family, and the availability and willingness of  





















Probands Relatives Simplex 
cases 
Controls 
001 Paris, France 3 0 0 3 0 
002 Nedlands, Australia 70 9 24 25 12 
003 Creteil, France 4 0 0 4 0 
004 Paris, France 56 12 22 22 0 
005 Los Angeles,  CA, USA 48 11 18 15 4 
006 Melbourne, Australia 50 13 17 10 10 
007 New York, NY, USA 35 10 18 3 4 
008 London, UK 106 20 49 35 2 
010 Cleveland, OH, USA 45 6 23 16 0 
011 Sydney, Australia 164 27 86 27 24 
012 San Diego, CA, USA 11 1 8 1 1 
013 Munster, Germany 61 19 20 9 13 
014 Tel Hashomer, Israel 37 9 13 13 2 
015 New York, NY, USA 14 2 6 4 2 
016 Fairfax, VA, USA 22 3 6 13 0 
017 Bonn, Germany 38 6 15 15 2 
019 Ann Arbor, MI, USA 73 15 28 20 10 
020 Madison, WI, USA 31 6 11 10 4 
021 Baltimore, MD, USA 5 1 1 2 1 
022 Philadelphia, PA, USA 8 1 2 5 0 
024 Bern, Switzerland 31 9 18 2 2 
025 Salt Lake City, UT, 
USA 
42 6 33 1 2 
026 Miami, FL, USA 50 9 11 30 0 
  
16 
Number of relatives 
enrolled per family 














Table 1b. Summary of the number of relatives examined per family in the MacTel cohort. 
 
Four diagnostic categories were established by the Moorfields Reading Center: affected, 
possibly affected, probably not affected, and unaffected. Representative findings for each 







Table 2. Imaging techniques used in the diagnosis of MacTel, and typical findings for each 
diagnostic category. 
Imaging Technique Diagnostic category Findings 
Color fundus Affected Loss of transparency and crystal deposit temporal to the fovea 
 Possibly affected Temporal drusen 
 Probably not affected No abnormal features 
 Unaffected No abnormal features 
Blue light reflectance Affected Clearly visible loss of transparency; telangiectatic temporal 
vessels; intraretinal crystals adjacent to region with loss of 
transparency 
 Possibly affected Slight loss of transparency temporal to the fovea 
 Probably not affected Questionable slight loss of transparency temporal to the fovea 
 Unaffected No abnormal features 
Fundus autofluorescence Affected Patch of increased autofluorescence temporal to the fovea 
 Possibly affected Increased autofluorescence temporal to the fovea 
 Probably not affected Questionable increased autofluorescence on the temporal to the 
fovea.  No other abnormal MacTel features 
 Unaffected No increased or decreased autofluorescence 
Optical coherence 
tomography 
Affected Abnormal retina architecture with inner and outer empty space; 
break in the inner segment/outer segment line at the fovea; 
intraretinal pigment absent Inner retina collapsing temporally to 
the fovea due to both inner and outer empty spaces   
 Possibly affected Mostly normal inner segment/outer segment line, with a small 
break, absent inner and outer empty space.  Absent intra-retina 
pigment. Questionable hyper-reflectivity on the temporal side. 
 Probably not affected Normal inner segment/outer segment line, no inner or outer 
empty space, normal retinal architecture. Absent intraretinal 
pigment. 
 Unaffected Normal inner segment/outer segment line, no inner or outer 




Figure 4. Retinal images from patients evaluated for MacTel. Top row: fundus 
autofluorescence; middle row: Color fundus; bottom row: optical coherence tomography. Panel 
A: Affected with MacTel; panel B: possibly affected; panel C: probably not affected; panel D: 
unaffected. Panel A shows the right eye, while panels B, C, and D show the left eye. Images 
were selected as those most representative of the diagnostic categories. Optical coherence 
tomography images (bottom row) are in color or black and white depending on how the image 
was saved by the technician.  
 
At the outset of the MacTel Project, the inheritance pattern was thought to be complex, since 
families with more than one affected relative were rare, and did not appear to conform to 
expectations for a Mendelian inherited disease. Prior to this study, affected relatives had rarely 
been recorded; it was thought all but a few MacTel cases were simplex. This view changed as a 
result of diligent examination of the relatives of MacTel probands in the course of 
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investigations by researchers in the MacTel project, including the work that comprises this 
thesis. 
 
A total of 51 families with more than one affected or possibly affected relative were identified 
in the course of this study. Of those families where all enrolled family members had been 
evaluated, 26% of the families had two or more relatives, including the proband, diagnosed as 
affected or possibly affected with MacTel. Notably, a large proportion of the simplex families 
consisted of families with only one relative screened in addition to the probands, suggesting 
that more familial cases of MacTel might be detected by screening additional relatives. A total 
of 429 relatives were enrolled, with confirmed diagnoses for 364 of those in April 2011. Of 
those relatives with a confirmed diagnosis, 32 were classified as affected, 38 as possibly 
affected, 61 as probably not affected, and 232 as unaffected. Altogether, 9% of relatives 
screened were diagnosed as affected. Including those relatives classified as possibly affected, 
19% of relatives were deemed likely to have either frankly diagnosable MacTel, or very 
suggestive retinal findings. Notably, those relatives classified as probably not affected were 
frequently ascertained in pedigrees where other relatives were diagnosed as either strictly 
affected or possibly affected. This suggests that the relatives diagnosed as probably not 
affected may be exhibiting some degree of MacTel phenotype, however these cases were 




Several factors complicate the assessment of inheritance patterns in families. MacTel is a late-
onset disorder. At the age patients generally present to a clinic with vision loss severe enough 
to seek treatment, the parents of the patient are in many cases deceased or unavailable for 
examination; any offspring tend to be too young to exhibit signs of the disease. There are 
exceptions, and families with vertical transmission have been ascertained, but the majority of 
families with multiple affected relatives consist of sibling pairs or trios, simply because these 
are the relatives that are available to be enrolled.  
 
GENETIC APPROACHES  
 
A decade after the announcement that the human genome had been sequenced (McPherson et 
al., 2001; Venter et al., 2001) the techniques available for genetic analysis are changing at such 
a rapid pace that methods that are reasonable at the end of this study were beyond the realm 
of consideration at its inception. Nonetheless, the most powerful techniques available to 
identify a susceptibility locus in an inherited disease rely on theoretical methods described near 
the beginning of the last century (Sturtevant, 1913; Fisher, 1922; Morton, 1955). 
 
Fundamentally, the goal of genetic disease mapping is to discover a functional variant in the 
genome that causes or contributes to a disease. In the simplest case, for a fully penetrant, 
monogenic, Mendelian disorder, a variant in a single gene is sufficient to cause the disease. 
Many of the human monogenic traits were mapped in the 1980s; genome-wide maps of 
naturally occurring polymorphisms have been exploited by researchers to discover thousands 
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of pathogenic alleles (Antonarakis and Beckmann, 2006). These discoveries contributed to the 
understanding not only of the causes of genetic disease in humans, but also fueled basic 
research by identifying molecular pathways that could be further studied in model organisms. 
 
CANDIDATE GENE SC REEN ING  
 
Given that most genes in the human genome are now known (current estimates place the 
number of protein-coding genes in the human genome at approximately 21,000 (Clamp et al., 
2007; Lander, 2011)), and the function of many of these have been at least partially elucidated, 
one approach is to review the literature for genes with known function and expression for 
which there is plausible evidence that the gene could be connected to the observed phenotype. 
These genes can be directly sequenced to look for variants that could cause or contribute to the 
disease. This method has several serious limitations: while much is known about the function, 
expression pattern, and interactions of genes, the collected knowledge is incomplete. Given the 
number of genes in the genome, the odds of picking the right one to sequence are daunting. 
Next is the difficulty of recognizing a disease causing variant when it has been genotyped. 
Taken alone, detecting a base pair variant that differs from the reference sequence confers 
little information. Outside information is needed to estimate the frequency of the allele in the 
population, and to determine whether it affects gene function. Additionally, for an inherited 
disease presumed to be caused by the same inherited allele in all affected members of that 




In this study, I used candidate gene screening by Sanger sequencing to evaluate genes with 
known retinal vascular or macular pigment transport phenotypes, genes implicated in diseases 
with phenotypic similarity to MacTel, and genes in a region of interest identified through family 
studies.  
 
L INKAGE ANALYSIS  
 
The availability of families with multiple affected individuals greatly increases the power of a 
genetic study (assuming they are affected due to shared genetic factors), and is the main 
strength of this endeavor. Family members will share a predicted proportion of alleles identical 
by descent because of Mendel’s laws. The expected shared proportion depends on the 
relationship of two individuals. For a parent-child pair, exactly one half of the genetic material is 
shared identical by descent. On average, a pair of siblings will share two alleles identical by 
descent across one quarter of the genome, one allele identical by descent across half the 
genome, and zero alleles identical by descent across one quarter of the genome. Relatives that 
share only one common ancestor will share one allele identical by descent across some fraction 
of the genome that becomes smaller the more distantly the two are related. The predicted 
allele sharing between family members can be used to look for regions of the genome that may 
harbor a gene that causes or contributes to a phenotype. 
Linkage analysis is a method used to determine whether two loci segregate independently. 
When applied to the genetic study of a disease, linkage is used to try to identify a gene that is 
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involved in the pathology of the disease by identifying a locus that segregates with the disease 
more often than would be expected by chance. 
 
With the availability of chip-based arrays to genotype single nucleotide polymorphisms, it is 
now trivial to determine the genotypes at millions of positions across the genome. Loci that are 
polymorphic can be used as markers in linkage analysis, meaning that it is possible to test many 
positions across the genome to determine whether a marker might be close to a gene involved 
in the disease. 
 
By the law of independent assortment, during meiosis, there is an equal probability that either 
of two copies of a chromosome will be segregated to a gamete. By virtue of this fact, loci that 
are on different chromosomes have a 50:50 chance of segregating to the same gamete or to 
different gametes during meiosis. During meiosis, homologous chromosomes pair and crossing 
over occurs at least once in every pair of chromosomes.  Two loci at opposite ends of the same 
chromosome will segregate independently as a result of the fact that a crossing over will almost 
certainly occur somewhere in between. When an odd number of cross over events occur 
between two loci, the resulting chromosome will be recombinant with respect to those two 
loci. Thus, when two loci are on different chromosomes, or far apart on the same chromosome, 
they will be inherited together 50% of the time, and they are said to be unlinked. When two loci 
are close together, a recombination event between them is less likely to occur. When this is the 
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case, alleles at the two loci will be inherited together more than 50% of the time, and the two 
loci are said to be linked.  
The principles of genetic linkage were first defined in Drosophila melanogaster where 
controlled matings could be arranged and the phenotypes of the progeny observed (Morgan, 
1910; Sturtevant, 1913). It was established that the recombination fraction, or the proportion 
of offspring in which a crossover occurred between two markers, could be quantified and 
analyzed mathematically to detect alleles that segregate together more often than would be 
expected by chance alone. It was later shown that this method could be applied to analysis of 
human families  (Haldane, 1934; Penrose, 1953; Morton, 1955), where statistical power 
depends on the size and pedigree structure of the families available for analysis (Ott, 1999). A 
genetic map defines the relative distance between syntenic loci by observing the number of 
recombinations observed between them. Genetic distance is measured in centiMorgans (cM), 
where one cM is defined as the distance between loci such that on average 1 crossover is 
expected between the two loci in every 100 meiosis. The recombination rate varies across the 
genome; on average, one cM corresponds to 1 million base pairs. Genetic maps of the human 
genome were made using markers that are highly polymorphic (Botstein et al., 1980), allowing 
the localization of disease genes to a small section of the chromosome. This led to the discovery 
of the genetic basis of many diseases that are caused by variants of a single gene, such as 
Huntington’s Chorea (Gusella et al., 1983) and cystic fibrosis (Rommens et al., 1988). Genetic 
maps were created using restriction fragment length polymorphisms (Donis-Keller et al., 1987), 
and later more closely spaced microsatellites (Dib et al., 1996), increasingly the resolution 
possible in a genome-wide linkage scan. More recently, high throughput chip technology 
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combined with data from the Human Genome Project and the HapMap Project has resulted in 
the availability of arrays to genotype thousands of single nucleotide polymorphisms (SNPs) very 
rapidly and affordably (Zhao et al., 1998; Li et al., 2008). SNPs are much less variable than 
microsatellites, as most SNPs are biallelic. The utility of a single polymorphism in linkage 
analysis is dependent on its frequency in the population, and on the accuracy of population 
data on allele frequencies (Albrechtsen et al., 2010). However, multiple SNPs can be combined 
in analysis to increase the information content, leading us to multipoint analysis of dense maps 
of informative markers, such that the resolution of linkage analysis is limited only by the 




At the outset of the MacTel project, it was unclear to what degree family studies would be 
possible. Until relatives of probands were examined systematically, the degree to which MacTel 
clusters in families was not evident. Several familial cases of MacTel had been reported, but 
most cases were thought to be simplex cases, with no additional affected relatives, as would be 
expected for a complex trait, caused by an unknown number of genetic and environmental 
factors. SNP chips have been used extensively in genome-wide association studies (GWAS) with 
mixed results (Weiss and Terwilliger, 2000; Altshuler et al., 2008; Hall et al., 2010; Rafiq et al., 
2010). GWAS depends on the detection of association between a single marker allele and a 
disease trait in cases and controls. Association is tested by comparing the frequency of an allele 
in cases to its frequency in controls. Such associations would exist if there were linkage 
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disequilibrium between one of the markers and a variant predisposing to disease (Terwilliger et 
al., 1998; Terwilliger and Goring, 2000; Clark et al., 2010).  
 
Association refers to a difference in allele frequencies between cases and controls. The 
presumption is that to identify a disease susceptibility locus, the identical allele will be over 
represented in a sample of cases as compared to controls. In the same way that the goal of 
linkage is to detect chromosomal segments that are inherited identical by descent in a subset of 
individuals in families (where the subset might be those people afflicted with a certain disease), 
association looks for segments of chromosomes inherited identical by descent in individuals 
who are very distantly related—so distantly that the last common ancestor is typically 
unknown, and the individuals in the sample would not consider themselves to be related. A 
statistically significant difference in the frequency of alleles at a locus between cases and 
controls may indicate that a functional variant exists in that region. A functional variant need 
not be the variant that is used to test association, but could be any variant that is syntenic with 
the marker and was also inherited identical by descent in a group of people with the disease or 
trait in question. Segments of chromosomes that have been inherited through many 
generations without recombination are referred to as linkage disequilibrium blocks, or LD 
blocks. 
 
The availability of chip arrays to genotype hundreds of thousands to millions of single 
nucleotide polymorphisms makes it possible to test for association across the genome with the 
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assumption that nearly every position on the genome will be in linkage disequilibrium with 
some marker represented on the chip. Studies of this kind are referred to as genome-wide 
association studies, or GWAS. Chip arrays that have typically been used in GWAS have upwards 
of 600,000 markers, requiring correction for multiple testing to reduce the number of expected 
false positives to an acceptable value. If the traditional threshold for significance of 0.05 were 
used in GWAS with 1 million markers, meaning that 1 in 20 positive results would be expected 
to occur by chance alone, the expected number of false positives would be 50,000. To reduce 
this number, a more stringent threshold for significance is required, and large sample sizes are 
required to achieve significance. 
 
In the MacTel study, GWAS was considered prior to the identification of multiplex families.  As 
enrollment proceeded, multiplex pedigrees amenable to linkage analysis were identified early 
on, and the decision was made to pursue linkage studies rather than GWAS. I have used 
association where variants were detected in candidate gene screening. Where rare variants 
were detected by Sanger sequencing in candidate genes, these variants were screened in 
MacTel cases and in a library of controls recruited and screened for AMD studies. The principle 
of association when applied in this way is the same as in genome-wide association, however 
testing a single variant reduces the need for correction for multiple testing, which dramatically 





EXOME SEQUENC ING  
 
Advances in next generation sequencing have recently progressed to the point that it is feasible 
for individual laboratories to carry out large scale sequencing rapidly, and at a reasonable cost 
(Ng et al., 2010b). The exome is defined as all regions of the genome that code for proteins (Ng 
et al., 2008). Whole exome sequencing became readily accessible in 2009 and 2010 as the cost 
of sequencing dropped, and sequence capture arrays were created to target the coding regions 
of the human genome (Hodges et al., 2007). In 2010, whole genome sequencing was not 
feasible for individual laboratories, though this has since changed. The rationale for targeting 
the exome is that many genetic diseases result from alleles in coding regions that alter the 
structure and function of proteins (Botstein and Risch, 2003; Ng et al., 2009). Coding variants 
are more tractable to identification, confirmation, and interpretation than non-coding disease 
causing variants. The main reasons to sequence the exome, as opposed the the genome, are 
cost, the lesser burden of dealing with large data sets (as compared to whole genome 
sequencing), and the notion that a change in amino acid sequence is easier to understand as a 
functional entity than a noncoding, or nongenic variant that may have a regulatory function (for 
example) that has not been characterized.  
 
We employed an approach similar to Ng et al. (Ng et al., 2010a) in which detected variants were 
filtered to remove common polymorphisms, synonymous variants, and variants not shared 
between affected siblings to reduce the number of candidates. While exome sequencing has 
proved useful in discovering diseases alleles for several monogenic diseases(Ng et al., 2010a; 
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Yan et al., 2011; Zuchner et al., 2011), our analysis was hampered by technical constraints that 
will be discussed in detail. Our experience was shared by other groups utilizing what was at the 
time a very new technology. The lessons learned from this experience extend to other 
emerging technologies. 
 
ANALYSIS  OF RISK HAPL OTYPES  
 
Recombination mapping in sibling pairs identified chromosomal segments where at least one 
allele was shared identical by descent in the affected siblings. I sought to extend this analysis by 
determining phased haplotypes in families to identify the alleles on the risk haplotype in each 
family, and to compare these haplotypes across families to determine whether a founder 
mutation could be detected. 
 
It was not expected that a single founder mutation would account for all cases of MacTel, but it 
was hoped that some proportion of cases would share a founder mutation that could be 
detected. Even allowing for a hypothesis of allelic or locus heterogeneity, haplotype analysis 
could theoretically reveal a risk haplotype enriched in the genomes of affected individuals. The 
goal of the analysis was to narrow the region of interest identified through linkage analysis.  
 
A haplotype describes the alleles inherited together from one grandparent for a set of markers. 
Haplotype analysis across families is a way of looking for linkage disequilibrium, recognizing 
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that “unrelated” individuals share common distant ancestry (Terwilliger and Goring, 2009). The 
hypothesis underlying this experiment is that some proportion of families with inherited 
disease may share a common ancestor who carried a founder mutation in some gene causing 
the disease. The shared haplotypes that can be identified in sibling pairs are necessarily large 
(on average recombination occurs every 100Mb, so the length of shared segments between 
members of a sib pair should average about 50Mb). Inspecting two informative meioses (an 
affected sibling pair), it is expected that 25% of the genome will be inherited by two sibs in such 
a way that no alleles are shared identical by descent, 50% will have one allele IBD, and 25% of 
the genome would have both alleles inherited IBD. In more distant relatives, either within a 
family, or between families that share a distant common ancestor, a greater number of meioses 
have occurred, and therefore proportionally less of the genome will be shared IBD. Haplotype 
analysis attempts to exploit the information that can be inferred from many generations of 
unobserved meioses, where a greater proportion of the genome will have recombined away 
from the risk allele, resulting in a minimal candidate region that is more narrow than that which 
could be observed in any given sibling pair. 
 
This method was chosen in this study in an attempt to narrow the minimal candidate region on 
chromosome 1q41-42. I will discuss how this method performed in families with parental 
genotypes present, and in families with missing parental genotypes, including the limitations of 
inferring phased haplotypes using population allele frequencies in a cohort with heterogeneous 
ethnicity, and the potential confounding factors related to genotyping error over a large 




INTRODUCTION TO CHAPTER THREE  
 
 
The following chapter consists of published work reporting the results of candidate gene 
screening by Sanger sequencing in a subset of family probands with Macular Telangiectasia. 
This work was carried out early in the project, during the early phase of enrollment of patients 
and families. Several genes were compelling candidates based on mutant phenotypes in mouse 
models with plausible similarity to aspects of the MacTel phenotype, and known disease 
association with human retinal diseases. While no associations were found between variants in 
any of these genes and MacTel, this analysis allowed us to rule out the exonic regions of these 
genes as harboring a causative variant for MacTel. Additionally, a compound allele in the Wnt 
receptor Frizzled-4 that had beeen previously reported to be a causative variant in another 




CHAPTER THREE –  ANALYSIS OF CANDIDATE GENES FOR MACULAR 




















STUDY POPULATION  
 



















Figure 1 Segregation of the p.Pro33Ser/p.Pro168Ser compound variant in 
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SUMMARY OF RELEVANCE  
 
This work represented the initial, hypothesis driven, effort to identify a causative allele for 
MacTel. While candidate gene screening has been successful in a limited number of cases, the 
odds of finding a risk allele by this method are extremely slim. Constructing a hypothesis for a 
role of any given gene in the pathology of a disease depends on prior knowledge of gene 
function, and the intracacies of networks of interacting gene products and signaling cascades. 
Our known universe in regard to molecular genetics is limited, whereas the true universe is 
vast. Even with this limitation, exhaustively testing the hypotheses that it is possible to 
construct based on reports of gene function in the literature is an unreasonable undertaking 
with low-throughput methods. That said, there were compelling candidate genes that we were 
able to rule out as harboring causative variants in coding regions by this method. At the time 
this work was carried out, the study cohort was not yet large enough to have any power to 
detect causative alleles through linkage, much less genome-wide association. This undertaking 
enabled me to construct criteria to evaluate variants by examining population allele frequencies 
from public databases, cosegregation of an allele with the disease in families, and allele 
frequencies in cases and controls in our cohorts. I later applied these criteria in evaluating 
variants in the linkage interval that was subsequently identified, as well as in defining an 





INTRODUCTION TO CHAPTER FOUR  
 
The work described in this chapter has been submitted for publication and accepted pending 
minor revisions. This chapter describes the first genome-wide linkage scan performed in MacTel 
families with multiple affected relatives. This work resulted in the identification of a region of 
statistically significant linkage on chromosome 1. Allele sharing identical by descent was 
determined in affected sibling pairs in an attempt to narrow the region of interest, and in 
preparation for whole exome sequencing, to define regions that could be excluded by virtue of 
no alleles shared identical by descent. The exons of genes in the region flanking the maximum 
LOD score were sequenced during a long delay pending the results from whole exome 











CHAPTER FOUR –  MACULAR TELANGIECTASIA TYPE 2:  LINKAGE TO 
1Q41-42  AND ANALYSIS OF THE LO CUS  
ABSTRACT 
Macular Telangiectasia type 2 (MacTel) is a relatively rare macular disease of adult onset 
presenting with distortions in the visual field and leading to progressive reduction in central 
visual acuity and loss of visual acuity. Several pedigrees were identified with multiple affected 
family members. Inheritance was consistent with autosomal dominant segregation with 
reduced penetrance. Genome-wide linkage analysis, analysis of recombination breakpoints to 
identify alleles shared identical by descent, and Sanger sequencing of positional candidate 
genes was performed to identify the genetic cause of MacTel.  Seventeen families with a total 
of 71 individuals (45 affected or possibly affected) were enrolled at clinical centers in 7 
countries under the auspices of the MacTel Project. Genome-wide linkage analysis identified  a 
single peak with multi-point LOD score of 3.45 on chromosome 1 at 1q41-42 under a dominant 
model. Recombination mapping identifying chromosomal segments shared by all affected 
individuals in a subset of families defined a 15.6 Mb candidate region encompassing the 1q41-
42 linkage peak . Sequencing of 14 genes flanking the maximum LOD score revealed no obvious 




Macular telangiectasia is a group of diseases characterized by Gass and Blodi in 1993 (Gass and 
Blodi, 1993) and recharacterized by Yannuzzi in 2006 (Iturralde et al., 2006). Macular 
telangiectasia type 2 (MacTel) generally presents bilaterally between the 5th and 7th decades of 
life with reduction in central vision and distortion in the visual field. The cause of the disease is 
unknown and there is no treatment.  
 
Clinical characteristics of MacTel include loss of retinal transparency, autofluorescence changes 
in the macula, macular edema, presence of intraretinal crystals, and disruption of macular 
pigment transport. Symptoms of advanced disease include the presence of a macular hole, 
dilated and tortuous vessels in the perifoveal region, leakage from retinal vessels and 
neovascularization arising from the intraretinal vessels (Chew et al., 2006; Charbel Issa et al., 
2007; Hannan et al., 2007; Charbel Issa et al., 2008a; Charbel Issa et al., 2008b; Charbel Issa et 
al., 2009b; Charbel Issa et al., 2009c; Finger et al., 2009; Aung et al., 2010). Patients experience 
distortions in central vision, including parafoveal scotoma, and metamorphopsia. Both genders 
are affected equally  
 
While MacTel had been presumed to be a very rare disease, recent epidemiological studies 
suggest that it is under-diagnosed and, therefore, more common than previously thought The 
Beaver Dam Eye Study recently reported a prevalence of 0.1% in a retrospective study of 4,790 
individuals, aged 43-86 years of age (Klein et al., 2010). The Melbourne Collaborative Cohort 
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estimated a probable prevalence of 0.0045% based on evaluation of 3,784 images where 
macular disease was noted, out of a study population of 22,415 participants (Aung et al., 2010). 
Both studies used available population data where retinal images had been obtained to assess 
other macular diseases in populations. In both studies, however, images had not been taken 
with the intent to diagnose MacTel; therefore both studies concluded that subtle features of 
MacTel were likely missed without specialized imaging, such as fluorescein angiography and 
blue light reflectance imaging. 
 
MacTel was proposed to have a genetic component based on case reports of affected sibling 
pairs and concordant monozygotic twins (Hutton et al., 1978; Chew et al., 1986; Oh and Park, 
1999; Menchini et al., 2000; Siddiqui and Fekrat, 2005; Hannan et al., 2007; Gillies et al., 2009). 
To test the hypothesis that MacTel is an inherited disease, family members of probands were 
actively recruited and given full ophthalmic examinations. Gillies et al. (Gillies et al., 2009) have 
previously reported four multiplex families included in this study. Additional multiplex families 
were subsequently identified, strengthening the hypothesis that variants in one or more genes 
underlie in the etiology of MacTel.  
 
The MacTel Project was established as a consortium of researchers and clinicians in order to 
study the natural history, identify the cause(s) of the disease, and propose targets for 
treatment. Patients were screened and enrolled at 23 clinical centers in seven countries 
(Australia, Germany, France, the U.K., Israel, Switzerland, and the United States). Family 
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members were actively recruited and given complete ophthalmic examinations. Seventeen 
multiplex families were identified that were informative for linkage analysis, together with 
additional parent-child duos Altogether, these data provided a basis for genome-wide linkage 
and recombination mapping analyses followed by sequencing of selected candidate genes from 




STUDY POPULATION  
 
Seventeen families with a total of 71 individuals (45 affected or possibly affected) were 
analyzed for linkage. The inheritance pattern in families with more than one affected individual 
was consistent with autosomal dominant transmission. MacTel exhibits reduced penetrance 
based on the observation that in some multiplex families neither parent is clearly affected with 
the disease. Variable disease expressivity is evident in many pedigrees in this cohort; while 
probands presented to the clinic experiencing vision loss, some relatives were given a  diagnosis 
of MacTel only after a complete ophthalmic exam as a part of this study. Retinal images from all 
recruitment centers (fundus photos, AF, OCT, etc.) were evaluated by a central reading center. 
The adjudicator was not informed of the diagnosis assigned by the recruitment center or 
whether the subject was a enrolled as a proband, relative, or control. All subjects were 
categorized as definitely affected, possibly affected, probably not affected, or definitely not 
affected. This clearly illustrates the variable expressivity of MacTel, complicating genetic 
analysis.  No gender bias was observed in patients, and male to female and female to male 
transmissions were both observed in the pedigrees.  Most families are too small to make a 
reliable estimation of the ratio of affected offspring, however, four large families had ratios of 
affected offspring consistent with autosomal dominant inheritance. Family 1 (Figure 6A) had 
four offspring, with two offspring affected, and one affected parent. Family 2 (Figure 6B) had 
seven offspring; two were affected, two were probably not affected, three were unaffected, 
and one parent was affected. Family 3 (Figure 6C) had six offspring; two were affected, one was 
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possibly affected, two were unaffected, and one was probably not affected. The parents in this 
family were unavailable for examination. Family 4 (Figure 6D) had ten offspring and two cousins 
in the third generation. Six individuals in the third generation were examined; three were 
affected. The parents and grandparents in this family were unavailable for examination, but an 
uncle in the second generation was affected.  
 
MULTIPOINT LINKAGE AN ALYSIS  
 
A total of 112 individuals in 33 MacTel families were screened on Illumina 1M Duo arrays. 
Seventeen informative families were analyzed by multi-point, affected-only parametric linkage 
analysis under an autosomal dominant model using a subset of SNPs from the Illumina 1M chip. 
Family members diagnosed as possibly affected were coded as affected. One significant peak 
was observed on chromosome 1, with a LOD score of 3.45 and HLOD of 3.54 (alpha=0.93) over 
an interval of approximately 15 Mb (Figures 7 and 8). Only one other region, on chromosome 5, 
yielded a positive LOD score over an interval of approximately 3.4 Mb (LOD=1.52, HLOD=2.43, 
alpha=0.76). Ten regions, totaling 13.2 Mb, had negative LOD scores between -2 and 0—not 
sufficiently negative for exclusion (Table 5.). The remainder of the genome yielded LOD scores 
below -2, sufficiently negative for exclusion. One large family (family 1) was split into two 
smaller families because of the large number of missing family members between the two 
branches. All families were linked to the peak on chromosome 1, with the exception of one 
branch of this large family. The individuals coded as affected in the unlinked branch all had a 
diagnosis of "possibly affected".  
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REC OMINATION MAPPING BY DETERMINATION OF IDENTIC AL BY DESC ENT SHARING  
 
IBD status was inferred along each chromosome with MERLIN (Abecasis et al., 2002), and only 
those positions where all affected individuals within a pedigree shared the same chromosomal 
segment were deemed consistent with the hypothesis of a necessary rare variant being located 
in a given genomic region. The full genome was analyzed for one trio of siblings and seven 
affected sib pairs, of which two had both parents (one affected in each family) genotyped. The 
results from the 8 families included in this analysis were then combined and the full genome 
was analyzed to map regions where exclusion was declared for at least one family; these 
regions were marked as excluded (Figure 9). Twelve chromosomes (chromosomes 3, 5, 6, 8, 10, 
13, 15, 18, 19, 20, 21, and 22) were entirely excluded (Table 5). Chromosomes 1, 2, 4, 7, 9, 11, 
12, 14, and 16 were partially excluded. In total, 153.81 Mb remained as potentially able to 
harbor a causal allele for MacTel under the assumption that a single copy of a single variant was 
necessary (but not sufficient) for disease (Table 5). 
 
COMPARISON OF IDENTIC AL BY DESC ENT TO LIN KAGE EXC LUSION  
 
Comparison of regions that were not excluded by either linkage analysis or by recombination 
breakpoint analysis revealed four regions that were not excluded by either analysis, including 
the significant linkage peak on chromosome 1. Three additional regions with LOD scores 
between 0 and -2 under autosomal dominant linkage analysis were not excluded by breakpoint 
analysis in strictly affected siblings: chromosome 7, 125.92-145.41 Mb; chromosome 12, 5.38-
7.03 Mb; and chromosome 14, 102.52-106.38 Mb (positions based on recombination analysis). 
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Reviewing regions of exclusion in these two different ways serves to clarify whether a 
chromosomal segment is excluded based on information from definitely affected individuals or 
possibly affected family members where the phenotype is less strictly defined. A total of 32.378 
Mb were not excluded by parametric linkage analysis, including the two regions of positive 
linkage. A total of 153.81 Mb were not excluded by the more stringent recombination 
breakpoint analysis based only on definitely affected siblings. 
 
GENE SEQUENC ING 
 
A 1.8 Mb region of the 15.6 Mb chromosome 1 linkage interval from 221,168,406-222,994,872, 
corresponding to the maximum LOD score, was selected for sequencing, which included 
thirteen genes and one micro-RNA.  All exons and flanking intronic regions of DISP1, TLR5, 
SUSD4, BEND5, CAPN8, CAPN2, TP53BP2, FBXO28, DEGS1, NVL, CNIH4, WDR26, and CNIH3 
genes and the micro-RNA, MIR320B2 were screened by Sanger sequencing in two affected 
family members, one from family 1 (individual IV4), the other from family 2 (individual III2). 
Each of these families consists of an affected sib pair, unaffected siblings, and two parents, one 
of which is affected in each family.  Altogether, only sixteen variants (confirmed by bi-
directional sequencing) were detected in coding regions of the 13 genes (Table 6) Six of these 
were synonymous variants; of the 10 non-synonymous variants, 5 were frequent 
polymorphisms, 2 were known variants of low or undetermined minor allele frequency that 
failed to segregate with the disease, and 2 were previously unknown missense variants that 
failed to segregate with the disease. One known variant with MAF=0.033, p.Val404Ile in NVL, 
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was detected in only one family, in which it is present in all affected family members, one 
possibly affected sibling, and no unaffected family members. However, this variant is more 






This study presents the first genome-wide linkage analysis of MacTel. The identification of 
multiplex families with the disease supports the hypothesis of a genetic component to the 
disease. Previously, we  investigated candidate genes by Sanger sequencing in the same cohort; 
however, no variants associated with MacTel were detected (Parmalee et al., 2010).  
We examined 17 multiplex families in a genome-wide linkage scan and detected significant 
linkage to 1q41-42, with a multipoint LOD score of 3.45. Assuming an autosomal dominant 
pattern of inheritance, and analyzing only affected and possibly affected individuals, all families 
were linked to this locus, with the exception of one branch of a large family that was analyzed 
as a separate family. Two relatives in the unlinked branch of family 1 were diagnosed as 
"possibly affected." One possibility is that this family is segregating a risk allele at a different 
locus; another possibility is that the two relatives are not actually affected with the disease. The 
detection of a significant linkage peak provides the first evidence of a possible susceptibility 
locus for this disease. 
 
Analysis of recombination breakpoints in strictly affected siblings defined chromosomal 
segments that were incompatible with inheritance of a rare disease allele. The results from 
individual families were combined to assess which regions across the genome are not excluded 
in any family, as would be expected if MacTel is a monogenic disease, caused by variants in the 
same region in all families. Two regions were identified on chromosome 1 that were compatible 
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with monogenic, autosomal dominant inheritance: one region corresponds to the region of the 
linkage peak; the other, smaller region is 5.3 Mb centromeric to the boundary of the linkage 
region (Figure 9). A second region of positive linkage on chromosome 5, with alpha=0.76, 
yielded LOD scores below the threshold for significance. This region was excluded in one family 
based on the observation of 0 alleles shared between affected siblings. This analysis was limited 
to affected sib pairs and one sibling trio that were diagnosed as definitively affected. Family 
members diagnosed as "possibly affected" were excluded from these analyses.  
 
MacTel was previously believed to be a disease with no discernable pattern of inheritance; 
however, in many families identified in this study, the disease appears to segregate as a 
monogenic, dominant trait. This does not preclude the possibility of genetic heterogeneity, but 
rather provides a starting point for genetic dissection of the trait in families. Intensive efforts 
have been undertaken by collaborators within the MacTel project to refine the definition of the 
phenotype and gain insight into the progression of MacTel. It is unknown at this point whether 
family members diagnosed as "possibly affected" are in the early stages of the disease and will 
eventually manifest full signs of MacTel, or whether these individuals carry modifiers that 
lessen the expression of the phenotype. It is noted that the median age of relatives diagnosed 
as possibly affected is younger than those relatives with a definite diagnosis. For the linkage 
analysis part of this study, we categorized "possibly affected" relatives as affected, given that, 
in the view of the Reading Center adjudicator, they exhibit signs of the diseases that are not 
typically seen in the unaffected population. While the ratios of affected to unaffected 
individuals in large families correspond well to the expected ratios for a Mendelian trait with 
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autosomal dominant inheritance, most families in the cohort are not large and, in most cases, 
parents are deceased or unavailable for screening due to the late age of onset of the disease. 
The observation that in some pedigrees parents of affected offspring are unaffected has 
suggested that MacTel is not fully penetrant. Whether this is due to locus heterogeneity, the 
presence of modifying alleles segregating in families, or environmental influences acting on an 
underlying genetic predisposition is unknown at this time. The chromosome 1 linkage region 
with a significant LOD score is the primary region of interest for a causative variant for MacTel. 
The second region of positive linkage, on chromosome 5, was excluded in the combined IBD 
analysis of affected siblings. Future work will include complete sequencing of the linkage region 
on chromosome 1,as well as other regions not excluded by IBD analyses, and analysis of 
additional families as they become available.
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MATERIALS AND METHODS  
 
STUDY C OHORT  
 
Patients, relatives, and controls were recruited at 23 participating clinical centers in 7 countries 
(Australia, Germany, France, The United Kingdom, Switzerland, Israel, and the United States). 
Informed consent was obtained at each participating clinical center in accordance with ethics 
protocols for human subjects approved by the appropriate governing body at each site in 
accordance with the Declaration of Helsinki. All protocols and records of consent were centrally 
managed by the EMMES Corporation (Rockville, Maryland).  
 
Participants were given a standardized ophthalmic examination, including best corrected visual 
acuity, fundus photography, fluorescein angiography, optical coherence tomography, and blue 
light reflectance. Images were adjudicated at the Reading Center at Moorfields Eye Hospital, 
London. Diagnoses were made in accordance with the criteria described by Clemons et al. 
(Clemons et al., 2010) based on Gass and Blodi (Gass and Blodi, 1993).  Retinal images were 
assessed for loss of transparency in the perifoveal region, dilated and telangiectatic blood 
vessels, especially in the temporal retina, and crystalline deposits. Each sample was assigned to 
one of four diagnostic categories: affected, possibly affected, probably not affected, or 




Peripheral venous blood was drawn from each participant and used to isolate DNA (Qiagen 
blood maxi kit 51194, Valencia, CA). DNA concentration was determined using the NanoDrop 
spectrophotometer (Thermo Scientific, Wilmington, DE). DNA samples of low purity were 
subjected to column purification (Qiagen blood and tissue kit 69504). 
 
GENOTYPING AND MARKER  SELEC TION 
 
Samples were genotyped on the Illumina 1M chip. The linkage marker set was selected by 
pruning stringently for genotype quality in GenomeStudio using the following parameters: 
GenTrain threshold ≥ 0.50, cluster separation ≥ 0.16, number of no calls = 0. The remaining 
markers were pruned for LD in PLINK (Purcell; Purcell et al., 2007) to remove markers with r2 
greater than 0.17. The final marker set consisted of 11,676 independent markers. An identity by 
state-based relatedness analysis was performed in PLINK using genome-wide marker sets to 
confirm family structures. 
 
L INKAGE ANALYSIS  
 
Parametric multipoint linkage analysis was carried out using MERLIN (Abecasis et al., 2002), 
with   risk allele frequency of 0.001, penetrance of 0.9 and phenocopy rate of 0 under the 
assumption that for a rare disease, affected individuals in a multiplex family are most likely 
affected for the same genetic reason. Affected only analysis was performed, with unaffected 
individuals coded as unknown. Possibly affected family members were coded as affected, under 
the rationale that they exhibited specific phenotypic signs consistent with MacTel, though not 
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sufficient for a definitive clinical diagnosis.  Allele frequencies were estimated from a total of 
112 individuals. Heterogeneity LOD scores and percentage of families linked to a locus (alpha) 
were calculated by MERLIN. As a confirmatory analysis that is less sensitive to model 
misspecification, we also performed a non-parametric linkage (NPL) analysis using MERLIN. 
 
Recombinations were mapped by determining IBD allele sharing using the NPL algorithm in 
MERLIN. Only definitively affected sib pairs and trios were included in the initial analysis to 
mitigate the possibility of excluding chromosomal regions based on incorrect diagnoses. Allele 
sharing was determined by comparing NPL scores from siblings to scores from a simulated 
dataset, to determine the values associated with each allele sharing state. Where parental 
genotypes were missing, segments with NPL scores of -0.3 (0 alleles shared) were excluded. 
Where parents were genotyped and one parent was affected, segments with NPL scores of -0.3 
(0 alleles shared) and -0.12 (1 allele shared from the unaffected parent) were excluded. 
Chromosomal segments with intermediate values were classified as ambiguous. The results of 
this analysis were aggregated to compile a genome-wide map of chromosomal segments where 
at least one allele was shared IBD in siblings in all families. This result was compared to 
parametric linkage results from the entire cohort to examine allele sharing in the linkage 
interval on chromosome 1, to validate exclusion by negative parametric LOD score, and to 







CANDIDATE GENE SEQUEN C ING  
 
Genomic DNA from two unrelated affected individuals was amplified using primers specific for 
exons in the genes of interest. PCR amplification was carried out using 2 ng of genomic DNA in a 
total volume of 25 μg, with 25 pmol each of forward and reverse primer, 200 μM dATP, dCTP, 
dGTP, dTTP, 2.5 mM MgCl2, 1.5 U Taq Polymerase (Hot Fire DNA Polymerase, Solis Biodyne, 
Tartu, Estonia, or AmpliTaq Gold, Applied Biosystems, Carlsbad, CA), and 10× buffer supplied by 
the manufacturer. Thermocycling was performed using either the Stepdown protocol, or the 
Touchdown (68–55 °C) protocol. Stepdown: an initial 12 min denaturation step at 95 °C was 
followed by 12 cycles of 95 °C for 12 s, 65 °C for 20 s (with a 0.5 °C reduction in temperature for 
each cycle), and 72 °C for 55 s. This was followed by 30 cycles of 95 °C for 12 s, 50 °C for 20 s, 
and 72 °C for 55 s, with a final 7 min extension at 72 °C. Touchdown (68–55 °C): an initial 12 min 
denaturation step at 95 °C was followed by 26 cycles of 95 °C for 15 s, 68 °C for 20 s (with a 
0.5 °C reduction in temperature for each cycle), and 72 °C for 45 s. This was followed by 15 
cycles of 95 °C for 15 s, 55 °C for 20 s, and 72 °C for 45 s, with a final 7 min extension at 72 °C. 
Sequencing was performed by Genewiz (South Plainfield, NJ). Primers were selected using 






































Figure 8. LOD, HLOD, and NPL scores for chromosome 1. The 1-LOD support 


































































Table 5. Exclusion based on parametric LOD score less than -2 under an autosomal 
dominant model. 
Chr Regions not excluded by parametric 
linkage (Mb) 
Regions not excluded by 
allele sharing (Mb) 
1 213.2 (2 markers) 
214.27-230.038 (LOD=3.43, 15.768 Mb) 
205.89-208.95 
214.32-229.92 
2 - 134.49-149.84 
240.24-243.12 
3 - - 
4 - 86.68-99.52 




146.41-149.78 (1.52 alpha=.76; 




6 - - 
7 136.74-137.33(0.59) 33.75-77.87 
125.92-145.41 
8 - - 
9 - 8.10-11.76 
78.0-86.35 
10 - - 
11 - 7.0-16.89 
12 6.62-7.16 (0.54) 5.38-7.03 
13 80.56-83.03 (2.47) - 
14 106.14-106.36 (0.22) 82.66-94.26 
102.52-106.38 
15 - - 
16 - 10.31-11.74 
17 - - 
18 - - 
19 - - 
20 - - 
21 - - 




Table 6. Variants detected by Sanger sequencing in two affected individuals. 
Syn = synonymous 
FV = frequent variant 
DNS = does not segregate with disease 




Gene Number of 
exons 
Variants detected MAF Notes 
DISP1 7 Unknown 75 g>a P25P 
Unknown 2835 a>g K945K 







TLR5 1 rs5744174 1846 T>C  F616L  





SUSD4 9 None   
BEND5 1 Unknown 986 g>a G329D  DNS 
CAPN8 19 rs35539373 734 c>a S245Y 





CAPN2 21 rs17599 1702 a>c K568Q  
Unknown 582 g>a A194A 
.292 FV 
Syn 
TP53BP2 (1, 12) 18 rs61749337 566 c>t A189V  





FBXO28 5 None   
DEGS1 (1) 3 None   
NVL (15, 22, 23) 23 rs7534447 456 g>a  R152R 
rs3754090 738 g>a L246L 







CNIH4 (3) 5 Unknown 48 t>g het F6V  DNS 
WDR26 13 None   
MIR320B2 1 None   
CNIH3 6 None   
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SUMMARY OF RELEVANCE  
 
The results described in this chapter represented the first indication of a potential susceptibility 
locus for MacTel. At the time these experiments were performed enrollment in the MacTel 
cohort was ongoing. Additional families with multiple affected relatives were soon identified, 
allowing us to repeat the linkage analysis with additional families. The findings from those 











CHAPTER FIVE –  WHOLE EXOME SEQUENCING,  ADDITION OF 












WHOLE EXOME A NALYSIS OF FOUR MACTEL PATIENTS  
 
INTRODUC TION  
 
Recent advances in massively parallel sequencing have made it possible to interrogate large 
regions of the genome at a cost, and in a timeframe, that was impossible even a short time ago. 
Over the course of this project, the methods chosen for sequencing have been determined by 
the research question at hand, but also by the cost and availability of sequencing technologies. 
This project has been carried out at a time of enormous technological change in the methods of 
genetic analysis. This is reflected in the approaches we have employed in the study of this 
disease. 
 
Exome sequencing represents a step between Sanger sequencing of small chromosomal 
segments and full genome sequencing. Exome sequencing is a type of targeting sequencing that 
uses large scale, high-throughput methods to interrogate selected regions of the genome, in 
this case, the protein coding portion of the genome. The advantage to exome sequencing at the 
time of this project was that a large number of bases could be interrogated at a cost far less 
than that of whole genome sequencing. Selecting regions of interest also reduces the 
information processing requirements necessary to interpret the large datasets that result from 




When this project was undertaken, sequencing the exome, using commercially available 
capture methods, was more cost effective than creating a custom library of probes to target a 
region of interest, and whole genome sequencing was still in the purview of large facilities, 
rather than independent laboratories. 
 
Exome screening as a technique for discovering disease causing variants rests on several 
assumptions. Foremost, this approach assumes that the disease under investigation is caused 
by a protein coding variant. Of equal importance, it assumes that a functional, disease causing 
variant can be discerned from a large number of variants not relevant to the disease phenotype 
(Ng et al., 2010b).  
 
The exome is defined as the totality of all protein coding regions in the genome. The intention 
of whole exome sequencing is to utilize high-throughput next generation sequencing to detect 
all variants in all exons in a genome. Many Mendelian genetic diseases for which genetic causes 
have been determined are attributed to variants in the coding sequence of a gene. Potentially 
functional coding variants are more readily interpretable in comparison to a reference 
sequence than non-coding variants. Variants in noncoding regions may be equally prevalent 




In 2009, Ng et al published a report in which the causal variant for Miller syndrome, a rare 
recessive disease, was detected by sequencing the exomes of two affected siblings and two 
additional unrelated patients (Ng et al., 2010a). The detected variants were filtered to remove 
synonymous variants, frequent variants, and variants not predicted to be damaging, resulting in 
a short list of candidates for further analysis. At the time of that publication, sequencing costs 
were becoming far less prohibitive than they had been previously, however whole genome 
sequencing was still beyond the reach of most laboratories. This situation would change within 
a year—an indication of the current rate of change in both technology and pricing. At the 
beginning of 2010, the cost to sequence one exome was $20,000, compared to a year later 
when the cost to sequence an exome is approximately $2,000, and the cost to sequence a 
whole genome is approximately $10,000, and dropping. 
 
Following the strategy of Ng et al., we selected two affected sisters, and two additional 
unrelated probands for whole exome sequencing, with the expectation that a causal variant 
would be inherited identical by descent in the two sisters. In the unrelated probands, a causal 
variant could be the same variant, identical by state—though we considered this to be unlikely 
given that MacTel is not a common disease—or another coding variant in the same gene, 








Sequencing and alignment was performed by Roche-454 (Connecticut). DNA quality was 
assessed by NanoDrop spectral analysis, OD 260/280 ratio, and molecular weight as assessed by 
gel eletrophoresis. Libraries were created using NimbleGen Sequence capture. Target 
sequences were amplified utilizing probes designed to capture 180,000 exons covering 34 Mb 
of the genome. Exon capture and sequencing was performed by Roche-454 using the GS FLX 
Titanium protocol. Alignment and mapping was performed using the GS FLX software package. 
Sequences were aligned against human genome assembly GRCh36 hg18. Known variants were 
identified based on dpSNP130. Final processed output was delivered in two forms: all variants, 
and high quality variants, as well as raw sequence reads. A variant was called if a base pair 
differed from the reference sequence on at least two non-duplicate reads, did not occur at the 
beginning or end of the read where the highest proportion of error is expected, and few other 
bases differed from the reference sequence for that read. Variants declared as “high quality” 
met all these criteria, and additionally were detected on both forward and reverse oriented 
reads.  
 
The number of variants reported per sample was compared to expectations for the total 
number of variants as compared to published whole exome projects. Selected variants were 
validated against Illumina 1M genotypes and Sanger sequence data for the same samples. 





The total number of variants reported for each sample is shown in Table 7. The number of total 
variants detected ranged from 89,208 in sample A98 to 107,866 in sample A39. The number of 
high confidence, unknown coding variants (the variant pool of interest) ranged from 194 for 
sample A98 to 303 for sample A39.  The average sample depth was 8.4x, indicating that, on 
average, each target was sequenced with approximately eight reads. Sequence was reported 
for between 83.8% and 91.1% of the targeted exome. The distribution of coverage across the 
genome was highly variable, with a small proportion of regions covered with many reads, but 
with much of the exome covered by only 3-5 reads (Figure 10).  
 
Table 7. Summary of the variants reported by sample, the percentage of the exome covered 




Figure 10. Plot of the number of bases (y-axis) covered by multiple reads (x-axis). 
 
To assess data quality, whole exome results were compared to heterozygotes detected on the 
Illumina 1M chip for these samples, and to results from Sanger sequencing. Approximately 30% 
of the heterozygous loci detected in coding regions on the 1M chip were also detected in the 
whole exome sequence. Similarly, approximately 30% of the variants detected by Sanger 
sequencing were also detected in the whole exome sequence, indicating that coverage of the 
exome in these samples was incomplete. In light of this, it was not possible to evaluate the 






Table 8. Comparison of heterozygous coding variants detecting by exome sequencing and by 




Table 9. Comparison of heterozygous coding variants detecting by exome sequencing and by 
Sanger sequencing in four samples. 
 
In the chromosome 1 linkage interval, no variants reported in the exome results were shared 
between the two affected sisters in family 8. By IBD analysis, it was determined that the two 
sisters share 2 alleles IBD in this region. Exome sequencing data indicated 1 private, unknown 
missense variant in A98 and 3 in A117 in this region. Analysis of all variants reported by exome 
sequencing in this region was similarly inconsistent with the previously established IBD allele 
sharing for these siblings. This inconsistency provided further indication that inadequate 





Table. 10 Unknown missense variants detected by exome sequencing on chromosome 1 from 
200 to 247 Mb (the 1q41-42 linkage interval and flanking regions). Allele sharing between the 
siblings A98 and A117 in the linkage interval from 214-299 Mb was inconsistent with allele 
sharing determined from the Illumina 1M SNP chip genotypes, which indicated that the siblings 
share 2 alleles IBD in this region. 
 
One unknown missense variant was detected in sample A117 in TGFB2, which is known to be 
involved in blood vessel regulation (Zhang et al., 2003). In the same gene, a different, known, 
missense variant was detected in A98, the sibling of A117, and a third known missense variant 
Gene Sample Amino acid 
change 










PPP1R12B A117 NK > TK 200676467-200676469 
 
23% 13 
ZC3H11A A117 F > L 202052855-202052856 
 
87% 8 
MAPKAPK2 A117 K > D 204972603-204972604 
 
100% 3 
CENPF A117 I > F 212858621-212858622 
 
36% 11 
TGFB2 A117 N > T 216676001 
 
89% 18 
CDC42BPA A117 KI > K* 225346236-225346238 
 
23% 13 
SPHAR A117 FY > LC 227507564-227507565 
 
50% 10 
C1orf107 A98 K > N 208078957 
 
67% 6 
USH2A A98 VL > VY 214661919-214661921 
 
18% 17 
FMN2 A180 R > Q 
 











OPN3 A180 R > Q 239824612 
 
57% 7 
OR2M3 A180 M > V 246432993 
 
56% 9 
PGBD2 A180 K > R 247178503-247178504 
 
45% 11 
LAMB3 A39 R > W 207869741 
 
33% 9 
OR2T8 A39 H > R 246151094 
 
75% 4 
OR2T34 A39 S > F  
 












was detected in A39, an unrelated proband. The 8 exons in this gene were sequenced by Sanger 
sequencing in all four of the samples submitted for exome sequencing. None of the variants 
reported by exome sequencing were confirmed by Sanger sequencing, indicating that false 
positives were also present in the data set. 
 
D ISC USSION 
 
This experiment revealed several practical limitations of exome sequencing. It was immediately 
apparent in the number of variants reported per sample that the overall number of variants 
was less than had been reported in similar studies. Our results significantly underreported the 
expected number of variants as compared to published reports and personal communication 
with other researchers. Additionally, the number of variants reported per sample was 
inconsistent. In sample A180, with an average of 8.9 fold coverage over 91.1% of the target 
region, 133,450 variants were detected. In sample A98, with an average of only 7.5 fold 
coverage over 83.8% of the target region, 89,208 variants were detected. These data strongly 
suggested that the detection of variants was incomplete, and was a function of poor coverage. 
Comparisons to genotypes from Illumina 1M SNP data and Sanger sequencing confirmed that 
only about 30% of the variants detected by those methods were reported in the whole exome 




While the coverage delivered was in the range of the project specifications as stated by Roche-
454, this level of coverage was inadequate to assess co-inheritance of alleles in the siblings A98 
and A117. Ng et al. (Ng et al., 2010a) and Choi et al.(Choi et al., 2009) achieved approximately 
40x coverage over 96 to 97% of the targeted exome. Other studies have sequenced to a fold 
coverage of at least 20x (Zhou et al., 2011) and as high as 100x (Yan et al., 2011). Choi et al. 
reported that the sensitivity to detect variants rose sharply between 5x and 20x coverage, and 
plateaued at 50x. While the sensitivity may vary depending on the read length and error rate of 
different sequencing technologies, published reports corroborate our results, indicating that 
the claims of sufficient sensitivity at 7-9x coverage for this technology were unfounded. 
 
In practice, identifying all portions of the genome that are transcribed and translated is not a 
trivial undertaking. During the course of this experiment, we became aware of limitations in the 
definition of the exome as applied in commercial sequence capture methods (personal 
communication from Michael Dean, National Eye Institute, and Jason Corneveux, Translational 
Genomics Research Institute). The target regions defined as the “exome” for both capture 
methods available at the time of this experiment, Nimblegen, and Agilent, were based on the 
consensus coding sequence database (CCDS). The goal of the CCDS project is “to identify a core 
set of protein coding regions that are consistently annotated and of high quality.”(Yan et al., 
2011) However, the CCDS lacks annotation for many transcribed genes, and annotation for 
isoforms of genes that are included in the CCDS is incomplete (Coffey et al., 2011). Thousands 
of known genes were not targeted at all by these capture methods, such that even with 
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complete coverage at the highest achievable sensitivity, any dataset produced by these 
methods would be necessarily incomplete. 
 
As these issues have been brought to light by researchers in the field, an expanded definition of 
the exome has been established in an effort to improve on these limitations. Lessons learned 
from inadequate coverage of target regions can be used to improve experimental design as the 













ADDITION OF FAMILIES TO THE LINKAGE COHOR T AND INDICATIONS OF G ENETIC  
HETEROGENEITY  
 
INTRODUC TION  
 
The analysis of additional families in a linkage study can reinforce a preliminary result, and 
narrow the region of interest. Additional evidence for the presence of a disease allele in the 
region of a linkage signal can be achieved by testing the effect on the LOD score when new 
families are added to the cohort. If a region identified by previous analysis co-segregates with a 
true susceptibility locus, the expectation is that the LOD score at the previously observed peak 
will increase. If an observed peak arose from the chance segregation of a region with the 
disease trait, the addition of more families decreases the probability of observing the same 
result by chance alone. If a region of positive linkage does not contain a disease allele, or if 
there is locus heterogeneity in the cohort, the expectation is that the LOD score will be reduced 
when additional families are added.  The region of interest may be narrowed if one or more of 
the families added to the cohort have regions of positive linkage over a more narrow interval 
than the larger region of interest. If locus heterogeneity is present, additional regions of 
interest may be identified. 
 
A linkage interval with a maximum LOD score of 3.45 was previously identified at chromosome 
1q41-42 by analyzing 17 families with multiple relatives diagnosed with MacTel. Following that 
analysis, DNA was obtained from seven additional multiplex families. These families were 
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genotyped and the cohort was reanalyzed for linkage. For two siblings of probands in the 
original cohort, diagnoses were updated from possibly affected to unaffected after images from 
follow-up examinations were analyzed by the Reading Center. These two families consisted of 
affected sibling pairs, and thus were excluded from further analysis as simplex cases. One new 
sibling pair was excluded from analysis after it was noted that the observed genotypes were 
inconsistent with the expected proportion of allele sharing for siblings. A total of 21 families 




Five affected sibling pairs, one affected trio of siblings, and a pair of affected cousins were 
genotyped on the Illumina 1M SNP chip, as described in chapter 4. Three of the families (F38, 
F43, and F184) were recruited in Australia, two were recruited in the United States (F159 and 
F204), and one (F188) was recruited in Germany. All individuals in these families reported 
European ancestry, and all relatives that were analyzed were diagnosed as strictly affected. 
 
All samples passed a genotyping quality control threshold with call rates greater than 99%. 
Genotypes from probands and relatives in the full cohort were reclustered, and the genotypes 
were inspected for quality metrics. The marker set of approximately 11,000 SNPs used in 
previous rounds of linkage analysis was applied to this cohort. These markers were screened for 
quality control in the reclustered genotypes as in previous analysis. Markers retained for 
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analysis were required to have a GenTrain score greater than or equal to 0.50, cluster 
separation greater than or equal to 0.16, and no missing genotypes. Markers that failed to pass 
any of these criteria after reclustering were excluded. Additional SNPs were added to replace 
those that were excluded. The resulting marker set consisted of 11,677 independent markers. 
 
Genotypes were analyzed in MERLIN as in previous experiments, using model parameters of 
penetrance = 0.9, risk allele frequency = 0.001, and phenocopy rate = 0. Both two point and 
multipoint analysis were performed. Allele frequencies were supplied from 128 individuals 
genotyped in the MacTel cohort. Affected and possibly affected individuals in the cohort were 
coded as affected. Unaffected individuals and relatives with a diagnosis of probably not 
affected were coded as unknown. The analysis was carried out as an affected only analysis to 
prevent miscoding of relatives as unaffected who may carry a disease allele but not express the 
MacTel phenotype given that our hypothesis is that MacTel is not fully penetrant. Additionally, 
many of the genotyped relatives are not yet of the age that they would be expected to manifest 
signs of the disease. Additional tests were performed with 1) only strictly affected individuals 
coded as affected (all others coded as unknown), 2) affected and possibly affected individuals 
coded as affected, unaffected individuals coded as such, and those with a diagnosis of probably 
not affected coded as unknown, and 3) affected and possibly affected individuals coded as 
affected, unaffected individuals under the age of 55 coded as unknown, and unaffected 
individuals over the age of 55 coded as unaffected. After observing the change in LOD score 
from that observed in the smaller linkage cohort, additional tests were performed excluding 
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individual families to determine the contribution of individual families to the changes in the 
LOD score. 
 
Recombinations were mapped in the newly added families in the region of the previously 
observed linkage peak at chromosome 1q41-42 using nonparametric analysis in each family to 
detect allele sharing states. This output was compared to previous results from affected sibling 
pairs and trios as described in chapter four to determine whether the minimal candidate region 
could be narrowed based on these data. Per family analysis was carried out to determine the 




Nonparametric analysis of individual families revealed that the sibling pair in family 159 showed 
no allele sharing identical by descent, indicating that these two samples did not originate from 
siblings. This family was excluded from further analysis.  The maximum multipoint LOD score 
obtained in affected only analysis with family 156 excluded (21 families analyzed) was 2.19, 
with HLOD = 2.92 and alpha = 0.81 at chromosome 1q41 (Figure 11). The peak spanned 
approximately 5 Mb, from 215 to 220 Mb. Previous linkage analysis had indicated a minimal 
candidate region of 15.6 Mb from approximately 214 Mb to 229 Mb. A second region of 
positive linkage was observed on chromosome 9p24-22. The maximum LOD score for this 
region was observed at rs10046838 (LOD = 1.25, HLOD 2.42, alpha = 0.72). The maximum HLOD 
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for this region was observed at markers rs10810584 and rs10115913 (LOD = 0.65, HLOD = 2.92, 
alpha = 0.75). All other regions of the genome produced negative LOD scores. Two additional 
regions produced HLOD scores above 2, though the LOD scores for these regions were weakly 
negative: one on chromosome 4 (rs7435692, HLOD = 2.43, alpha = 0.64), the other on 
chromosome 13 (rs182977, HLOD = 2.39, alpha = 0.73).  
 
The cohort was reanalyzed for linkage with only relatives diagnosed as strictly affected coded as 
affected. Relatives with a diagnosis of possibly affected were coded as unknown to control for 
the possibility of misdiagnoses. A maximum LOD score of 2.49 (HLOD = 2.61, alpha = 0.90) was 
observed at chromosome 1q41, at the same position observed when possibly affected relatives 
were coded as affected. Two additional regions of positive linkage were observed on 
chromosomes 9 (LOD = 1.74, HLOD = 2.76, alpha = 0.85) and 4 (LOD = 1.20, HLOD = 2.22, alpha 
= 0.82), in the same regions as noted above. 
 
When the same analysis was performed with unaffected relatives coded as such, no evidence 
for linkage was observed; LOD scores were negative at all loci. This result was not surprising, 
given that many relatives in the samples are much younger than the typical age of onset for 
MacTel. Relatives who are too young to be expected to manifest the MacTel phenotype yet 




To control for miscoding of relatives resulting from age of onset effects, the unaffected 
relatives in the cohort were recoded as unaffected only if they were over age 55; unaffected 
relatives under age 55 were coded as unknown. This resulted in a maximum LOD score of 1.19 
(HLOD = 1.86, alpha = 0.74) at the same position on chromosome 1 as observed in the affected 
only analysis. All other linkage scores across the genome were negative. This result was 
consistent with our hypothesis of reduced penetrance in the MacTel phenotype under the 
presumption that the linkage signal on chromosome 1 in the affected only analysis reflects a 
true susceptibility locus. 
 
Inspection of allele sharing states in individual families across the previously identified linkage 
interval indicated that in four of the newly added families, siblings shared either one or two 
alleles identical by descent across the 1q41-42 region, compatible with a shared autosomal 
dominant risk allele in this region (Figure 12). Family 188, a pair of cousins, showed 0 alleles 
shared IBD on chromosome 1. Inspection of allele sharing across the genome in this family 
showed 1 allele shared IBD across ~13% of the genome, consistent with expected proportion of 
allele sharing for cousins. Family 171, an affected sibling pair, showed 0 alleles shared across 
most of the linkage region. A recombination was mapped to the region between 214 and 218 
Mb near the centromeric boundary of the previously established minimal candidate region. This 
recombination failed to resolve more precisely by analyzing additional markers. From 
approximately 206 Mb to approximately 214 Mb the siblings shared 1 allele IBD, compatible 
with a co-inherited susceptibility locus. Allele sharing between 214 and 218 Mb remained 
ambiguous. From 218 Mb to the telomeric boundary of the linkage interval, the siblings shared 
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0 alleles IBD, indicating that the rest of the linkage interval is incompatible with a co-inherited 
susceptibility locus in this family. 
 
Figure 11. Linkage scores for the full cohort, analyzed with affected and possibly affected 
relatives coded as affected, and all other relatives coded as unknown. HLOD scores are shown 
in red, LOD scores are shown in black. Negative LOD scores are not shown. Positive LOD scores 
were observed on chromosomes 1 and 9. Regions of suggestive linkage based on heterogeneity 
LOD scores were observed on chromosomes 9, 4, and 13. 
 
 
To determine which families were driving the reduction in LOD score from the previous linkage 
result, the analysis was repeated excluding the families 171 and 188 that were not linked to the 
1q41-42 locus as determined by evaluation of IBD allele sharing. Excluding these two families, 
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the multi-point LOD score was 5.46 at chromosome 1q41-42, with HLOD = 5.46 and alpha = 1.0, 
indicating that all remaining families are linked to this locus. The previous result, before the 
addition of these families, resulted in a LOD score of 3.45 in the same region, with HLOD = 3.54 
and alpha = 0.93. In that cohort, one large family was analyzed as two separate families 
because of the large number of missing individuals between the two branches of the family. 
One branch of that large family was not linked to the 1q41-42 region; the affected relatives in 
that branch were diagnosed as possibly affected. When only F171 was excluded, the maximum 
observed LOD score was 4.27 (HLOD = 4.29, alpha = 0.97), at 1q41, confirming that the 
narrowing of the linkage interval was due to the contribution from this family, consistent with 
the observed allele sharing in this region. When only F188 was excluded, the maximum LOD 
score observed was 5.12 (HLOD = 5.12, alpha = 1) at 1q41, indicating that all remaining families 





Figure 12. IBD allele sharing in seven new multiplex MacTel families. Family 159 showed no 
alleles shared IBD across the genome, indicating that the two individuals are not siblings. This 
family was excluded. Family 188 (cousins) showed no allele sharing IBD on chromosome 1. 
Family 171 showed a region near the centromeric boundary of the 1q41-42 where IBD allele 






Figure 13. Linkage tests excluding families that did not exhibited allele sharing IBD in the 
region of interest on chromosome 1q41-42. Graphical output was generated by MERLIN. LOD 
score is indicated on the x-axis (the scale of the x-axis varies between graphs). The gray line at 
LOD 3 indicates the consensus value for rejection of the null hypothesis of no linkage. The gray 
line at LOD -2 indicates the value below which linkage is considered to be significantly rejected. 
The two left panels show the region of maximum linkage to be narrowed when family 171 is 
included in the analysis. The bottom two and the top right panels show that the maximum LOD 
score is increased when either family 171, family 188, or both are excluded from analysis. This 
result shows that the position of the linkage interval is unchanged from the previous linkage 
result when family 171 is excluded, and the reduction in LOD score from that result is due to 







D ISC USSION 
 
The observation of families unlinked to the primary MacTel susceptibility locus on chromosome 
1q41-42 provided the first evidence of locus heterogeneity contributing to the MacTel 
phenotype. Locus heterogeneity is well known in other genetic ocular diseases, for example 
Leber congenital amaurosis (den Hollander et al., 2008), familial exudative vitreoretinopathy 
(FEVR) (Shastry et al., 1993), and retinitis pigmentosa (Daiger et al., 2007). Because the 
recombination in this region in family 171 is mapped ambiguously, it remains uncertain 
whether this family is linked to only a narrow region of the 1q41-42 locus, or whether the entire 
region is excluded in this family. The observation that family 188 is not linked to any portion of 
this region provides the first evidence of locus heterogeneity in the MacTel cohort. Given this 
observation, and the fact that in any one family 75% of the genome will be compatible with an 
autosomal dominant inherited allele by coincidence, exclusion of any portion of the linkage 
interval based on the inheritance pattern in only one family could be spurious. That is to say, if 
family 171 is linked to only a narrow region of the larger interval, that linkage could arise 
because a true susceptibility locus exists in the narrow region, or it could arise by chance. There 
is insufficient evidence at this time to discriminate between these two possibilities. Thus, given 
that additional families have been identified with demonstrated linkage to the 1q41-42 locus, 
this broad region remains of interest as possibly harboring a risk allele for MacTel. However, the 
observation of unlinked families indicates that other loci may to contribute to the phenotype, 




PHENOTYPIC HETEROGENEITY IN MACTEL 
 
Evaluation of the MacTel phenotype has identified variable expressivity in affected individuals 
even in families where presumably all affected relatives have inherited the same causative 
allele. This observation has persistently raised the question of whether MacTel is caused by 
alleles at one locus, whether more than one contributing locus is necessary to generate the 
phenotype, or whether modifying alleles and/or environmental factors affect the expression of 
the phenotype. Segregation of the disease in the few large families that have been evaluated is 
consistent with the inheritance pattern expected for a single segregating allele, thus, we have 
referred to MacTel as a Mendelian disorder in these families. This does not preclude the 
possibility that entirely different alleles, at different loci, could be segregating in different 
families, as in retinitis pigmentosa (Daiger et al., 2007) for example, where many distinct loci 
are known to cause the disorder, which segregates in a Mendelian fashion in those families.  
 
The observation of genetic heterogeneity in the MacTel family cohort raises additional issues 
that must be taken into consideration in dissecting the susceptibility locus. When considering 
any given pair of siblings, on average, 2 alleles will be shared IBD across 25% of the genome, 1 
allele will be shared across 50% of the genome, and 0 alleles with be shared IBD across 25% of 
the genome. Thus, 75% of the genome is compatible with inheritance of an autosomal 
dominant disease allele in any given affected pair of siblings. The power of this, or any, study 
comes from the analysis of many informative meioses, and from large families where the 
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expected proportion of the genome inherited identical by descent is much smaller due to the 
combined probabilities of any given region segregating to a gamete in multiple meioses. 
Linkage between a marker locus of known position and a disease locus of unknown position is 
declared when the observed data indicate that it is statistically improbable that the same 
region would be inherited identical by descent in many families, or in all affected relatives in a 
large family by chance alone. 
 
When all families are linked to a presumed susceptibility locus with a significant LOD score, it is 
reasonable to assume for the purposes of further study that there is a true disease locus in the 
region of interest in all families. However, the possibility remains that such a presumption is an 
over simplification, and if more families were sampled, evidence for additional loci would 
emerge.  
 
Given the observation of families not linked to the 1q41-42 locus, each family under analysis 
has a probability of demonstrating linkage to the region of interest by chance alone. It remains 
questionable whether family 171 is linked to the most centromeric region of the 1q41-42 locus 
given the inability to accurately resolve the recombination in the region in that family. There 
are three possible interpretations of the result: the recombination is centromeric to the linkage 
interval, in which case the family is not linked to the region of interest; the recombination 
occurred within the interval, and the siblings carry an inherited disease allele in the narrowed 
linkage interval; the recombination occurred within the interval but the siblings do not carry an 
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inherited disease allele in this region, rather allele sharing consistent with autosomal dominant 
inheritance occurred by coincidence. Given the evidence, it is not possible to determine which 
of these possibilities is the true condition. Parental genotypes are not available for these 
siblings. If additional siblings became available for genotyping, this added information would 
assist in reconstructing the parental genotypes such that the recombination might be 
accurately resolved. This could answer the question of whether the family is linked to the 1q41-
42 locus, but would not indicate whether or not a true disease allele is present in the interval. 
 
Depending on the true linkage status of family 171, either one or two families out of 21 are 
unlinked to the 1q41-42 locus. This observation enables an estimation of the proportion of 
families linked to the region, with the caveat that sampling error is likely in this small number of 
families. The estimation can serve as a rough guideline for how much confidence should be 
placed on the contribution of any single family. If 1 in 10 families do not carry a disease allele in 
the 1q41-42 region, any given family has a 90% chance of carrying a true risk allele in that 
region. Further genetic dissection of the interval must be interpreted with this caveat in mind. 
 
The observation of suggestive heterogeneity LOD scores on chromosomes 9, 4, and 13 provides 
some evidence, albeit weak, for additional loci that could contribute to the MacTel phenotype. 
Enrollment in the MacTel study is ongoing; if additional multiplex families are identified, further 
linkage analysis may be warranted. As more families are sampled, the possibility increases of 
ascertaining families that harbor risk alleles in other regions, if these exist. While this would 
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partition the power of the cohort overall, it would increase the power to detect significant 








HAPLOTYPING OF AFFECT ED SIBLINGS  
 
INTRODUC TION  
 
A haplotype is the set of genetic material inherited in a single gamete. The defining feature of a 
haplotype is that a group of alleles together without recombination. For the purpose of 
searching for a disease allele, it is of interest to identify chromosomal segments inherited 
identical by descent in a pair of relatives.  Sequencing or genotyping reveals which alleles are 
present in a genome, but provides no information as to the phase of the alleles, that is to say 
whether an allele is present on the maternally or the paternally contributed chromosome. 
Determining the phasing of alleles allows identification of the alleles on a putative risk 
haplotype. These alleles can then be compared across families. 
 
The prediction that a shared risk haplotype might be present in unrelated families rests on the 
premise that “unrelated” families share a distant common ancestor, and that a risk allele could 
exist on a haplotype coinherited with the disease. The alternative hypothesis is that disease 
causing alleles have arisen de novo in multiple lineages as separate events. If the first scenario 
were true, the expectation would be that the risk allele would be identical across families. If the 
second scenario were true, the expectation would be that either locus heterogeneity, allelic 
heterogeneity, or both would be observed across families. Cystic fibrosis (CF) provides an 
example in which elements of both are observed. Over 1,800 variants in the CFTR gene have 
been identified, but approximately 70% of Caucasian patients are homozygous for the 
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p.Phe508del variant (Cutting, 2010). The presence of a common risk haplotype was exploited to 
narrow the region of interest in order to identify CFTR as the gene responsible for CF (Rommens 
et al., 1988). 
 
The goal of this analysis was to identify phased risk haplotypes in affected siblings, compare the 
genotypes of the risk haplotypes across families, and determine whether a common haplotype 
was enriched in families with inherited MacTel in the region of the linkage peak on 
chromosome 1q41. Recombinations had been previously mapped using the NPL algorithm in 
the analysis of IBD allele sharing, so this effort was not expected to narrow the minimal 
candidate region based on allele sharing, rather to discern phase information in the siblings in 
order to be able to compare genotypes across families in an attempt to detect a shared 




The genotypes of all probands and relatives in the linkage cohort were analyzed in MERLIN 
using the haplotype function. All available relatives were included in the analysis, without 
regard for diagnostic status. The analysis was performed using the set of chromosome 1 SNPs 
employed in linkage analysis, as well as a dense marker set in the region of interest consisting 
of all SNPs that passed the minimum quality control threshold as described in previous sections. 
To address the potentially confounding issue of ethnic heterogeneity in the study cohort, an 
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additional marker set was created by removing SNPs with MAFs that are very different between 
HapMap populations in an effort to reduce potential bias arising from the use of mismatched 
population allele frequencies. Population allele frequencies for SNPs in the region of interest 
were compared across 11 populations for which data was available in dbSNP (YRI, TSI, MKK, 
MEX, LWK, JPT, GIH, CHD, CHB, ASW, CEU (International HapMap Project, 2011). SNPs with 
allele frequencies that vary across these populations were identified by determining the 
standard deviation of the minor allele frequencies across all these populations. SNPs with a 
standard deviation greater than .10 were excluded. Markers were analyzed from 214-221 Mb 
on chromosome 1, flanking the 1q41 linkage peak described earlier in this chapter. 
 
The output of the analysis consisted of two datasets for each family, one indicating the 
grandparental origin of each locus (designated A, B, C, or D), the other giving the corresponding 
genotypes. The phased haplotypes for affected relatives were compared to IBD allele sharing 
states as previously determined using nonparametric analysis as a control for consistency of 










Applying a dense marker set consisting of all high quality SNPs in the region from 215-221 Mb, 
phased haplotypes and the corresponding genotyped were successfully resolved for families 8 
and 156, where both parents were genotyped in each family (Figure 14). Comparison of these 




Figure 14. Pedigrees of family 156 (left) and family 8 (right) showing phased haplotypes in the 
region of the linkage interval on chromosome 1q41. Black pedigree symbols indicate affected 
individuals, open symbols indicate unaffected individuals, and gray symbols indicate individuals 
who had some abnormal characteristics on examination but were not diagnosed as affected 
with MacTel (designated “probably not affected”). The risk haplotypes are showed in red and 
starred. In offspring, the paternally contributed chromosome is shown on the left, the 




A comparison of the alleles on the putative risk haplotypes in families 156 and 8 was of limited 
utility (Figure 14). An unwieldy number of regions showed exact matching of genotypes 
between the two families. The markers compared between the two families were identical 
between siblings within each family, to control for genotyping error. However, in most 
instances, runs of identical genotypes were interrupted by only one or two discordant markers. 
The largest region of identical genotypes occurred between 218.3 and 219 Mb, interrupted by 
two discordant markers at 218.6 Mb. The position of maximum LOD was observed at 218.2 Mb. 
 
 
Figure 14. Comparison of genotypes in F8 and F156. A value of 1 indicates the genotypes are 
the same, and a value of 0 indicates that they differ. 
 
All other families analyzed consisted of sibling pairs or trios with parental genotypes missing. In 
these families, the haplotype output was inconsistent with IBD allele sharing states as 
previously determined. The data indicated as many as 9 crossover events in a span of 30 Mb, 
inconsistent with the expected recombination frequency of 1 per 100 Mb, indicating an error in 
the method. Output from a sparse set of high quality markers mapped fewer recombinations, 
but still indicated false recombinations based on the recombination rate that would be required 
to produce such a result. Low resolution mapping also resulted in output where the phase was 
ambiguous over large portions of the region of interest.  
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In an attempt to resolve the issue, a marker set of 981 SNPs, filtered to remove SNPs with MAFs 
with a standard deviation greater than 0.10 between HapMap populations was applied, with 
similar results.  
 
D ISC USSION 
 
The results achieved using this method identified many regions where alleles on the putative 
risk haplotype were shared between affected relatives in families 156 and 8.  The largest region 
was observed from 218.3 to 219 Mb. However, genotypes were shared at numerous positions. 
The results in other families indicated a serious deficiency in the method as applied to the 
families in this cohort. Examination of population LD blocks using the CEU analysis panel in 
Haploview showed 26 LD blocks in the region between 218-219 Mb, spanning the longest 
segment of genotype sharing in families 156 and 8 (Figure 16). This region contains nine genes, 
none of which have been screened. However, this is only a portion of the linkage interval; there 





Figure 16. Linkage disequilibrium in the CEU population, visualized in Haploview (HapMap 
Phase 3, release 2 data). 
 
This analysis was severely limited by the inability to resolve phased haplotypes in sibling pairs 
and trios where parental genotypes were missing. Niu et al. (Niu, 2004) described several 
computational methods for inferring haplotypes. Inferring haplotypes from nuclear families 
with absent parental genotypes, requires the evaluation of all possible phase configurations 
based on a limited amount of observed data. Niu notes that MERLIN performs well in large 
pedigrees with highly informative markers where there are fewer ambiguities to resolve, but 
has been observed to perform less well in the analysis of sibling pairs. Whereas the output of 
the NPL statistic in MERLIN is a probability of allele sharing, allowing ambiguity to be observed 
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and interpreted, the output from the phased haplotype analysis does not include a metric to 
interpret the confidence that should be assigned to the result. The phasing of genotypes is 
declared in a binary fashion by this method, even when confidence in the result should be low. 
Results can be compared to expectations of recombination rates, and to other analyses, such as 
IBD allele sharing, to determine whether the output conforms to reasonable expectations. In 
the case of most families available for analysis in this study, it did not. 
 
In families 156 and 8, where parental genotypes were available, and haplotypes were well 
resolved, the putative risk haplotype was inherited by two unaffected and one possibly affected 
relative in family 156, and by one unaffected sibling in family 8. Taken alone, these data 
indicate that this haplotype does not segregate with the disease in these families. Given that 
heterogeneity was observed by linkage analysis, as described in the first section of this chapter, 
it is entirely possible that the positive linkage scores observed in one or both of these families 
under affected only analysis were spurious. A second hypothesis is that there is a true risk allele 
on this haplotype, but it is not sufficient to cause the disease. This hypothesis is consistent with 
the hypothesis of reduced penetrance in MacTel. The comparison of affected only versus 
affected-unaffected linkage analysis indicated that, if there is a true risk allele in the 
chromosome 1q41-42 region, some relatives diagnosed as unaffected are linked to that region, 
since the linkage signal was abolished when all unaffected were coded as such. Thus, observing 
unaffected relatives who carry the putative risk haplotype is consistent with other analysis. The 
linkage score observed at chromosome 1q41-42 remains the strongest evidence the existence 
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of a susceptibility locus for MacTel. This region continues to be of interest, with the caveat that 



















CHAPTER SIX –  SUMMARY AND CONCLUSIONS  
SUMMARY OF RESULTS  
 
In this work, I have analyzed the first cohort of MacTel patients and their families in 
collaboration with other researchers in the MacTel project. During the course of this project, 
significant work has been done by others to refine the MacTel phenotype, and study the 
epidemiology of the disease. These efforts support the genetic analysis. Findings related to 
macular pigment distribution suggest that defects in these pathways may be primary in the 
etiology of the disease. Retinal vascular effects may occur subsequent to disruptions in macular 
pigment distribution, but the specificity of the neovascular phenotype still suggests that there 
may be an underlying genetic predispostion that predisposes the intraretinal vessels to become 
dysregulated. It is conceivable that a common regulatory pathway might impinge on both 
macular pigment transport and intraretinal vascular regulation, though this remains speculative 
pending the identification of a causative gene for the disease. The implication of Mueller glia 
cells in the MacTel phenotype (Powner et al., 2010) is significant, in that it is supposed that 
these cells play a role in macular pigment transport and deposition in the retina. Mueller glia 
cells are also in contact with intraretinal vessels. A single gene expressed in these cells could 
play a dual role, affecting both macular pigment transport and vascular homeostasis, or 
multiple genes, coexpressed in the same location could interact to affect both systems. 
Functional studies will be required to answer these questions if genes involved in the 
pathogenicity of MacTel are discovered. 
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At the outset of this project, the hypothesis was made that MacTel is in fact a genetic disease. 
This hypothesis was tested by examining the family members of probands with full ophthalmic 
examination and imaging adequate to detect the phenotype. The first major finding of this 
work, due to the efforts of the clinicians at the MacTel recruitment centers and the Moorfields 
Reading Center, was to identify families with multiple relatives affected with MacTel. The 
second significant finding was that the inheritance pattern is consistent with autosomal 
dominant inheritance, suggesting that the disease could be Mendelian in these families. 
 
Significantly, it has not been possible to classify each family member as either affected or 
unaffected. The four categories of diagnostic status employed in this study—affected, possibly 
affected, probably not affected, and unaffected—may represent different stages of the disease, 
or may represent different presentations of the disease. So while it was a significant step to 
identify families with inherited disease, we also observed that the phenotype is variably 
expressed. 
 
At the outset, it was believed that MacTel was a multifactorial trait. This may be the case, but 
the indication at this point is that, in some families, the expression of the phenotype may be 
controlled by large effects of a small number of factors, rather than small effects of many 
factors. In the few large families in the study, the ratio of affected to unaffected offspring is 
close to the 50:50 ratio that would be expected for  a fully penetrant disorder with autosomal 
dominant inheritance. The question remains as to whether relatives that have been diagnosed 
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as possibly affected carry a modifying allele that affects the expression of the phenotype, 
whether environmental factors affect expression, or whether the disease is not significantly 
different in these patients, but they are in the early stages. The last point will be answered as 
these patients are followed clinically. The first question may be addressed if a causative gene is 
identified, but more families would be needed to sufficiently power a linkage study to identify 
modifying alleles. The question of possible environmental effects will remain difficult to answer 
with certainty. 
 
In this work, I have described negative results from Sanger sequencing of 40 candidate genes, 
27 of which were selected based on functional criteria, and the remainder selected based on 
their position under the chromosome 1 linkage peak. The exons of these genes were sequenced 
in probands from families with multiple affected relatives. Rare or unknown missense variants 
were screened in a cohort of unrelated MacTel patients, and in a large cohort of screened 
controls. Such variants were also screened in the relatives of the family in which they were 
detected to determine whether or not the variant co-segregated with the disease. The criteria 
for declaring a variant to be a putative causative variant for MacTel were that it would be 
present in all affected relatives in the pedigree in which it was detected, and that it would not 





The failure to detect a causative variant by candidate screening was not surprising. That portion 
of the work was undertaken during the early enrollment portion of the study, before a 
sufficient number of individuals had been enrolled to provide power for other analysis 
methods. While there was always a low probability of finding a causative allele with that 
method, there is extensive literature on the molecular genetics of retinal vascular pathways in 
the retina, and to a far lesser degree, the pathways that contribute to macular pigment 
transport. It is entirely possible that the pathways selected for screening may play a role, but in 
many cases, it is simplistic to use the term “pathways” given that these are actually networks of 
gene products, with many interacting gene products. In some cases, such as the Norrin/Frizzled-
4/LRP5 pathway, I screened several known interacting genes. However, there are many more in 
this pathway alone that I did not screen. The same can be said for most of the genes that were 
screened. Candidate genes were selected based on the strongest evidence from the literature 
for genes with phenotypic similarity to the MacTel phenotype, but many interacting proteins, 
both known and unknown, could impinge on the same pathways, making and exhaustive screen 
by direct sequencing next to impossible. As an interim approach during early enrollment phase, 
it was a reasonable approach, given the low cost of Sanger sequencing, until more powerful 
methods were available. 
 
Additionally, candidate gene screening only queried the exons and exonic flanking regions of 
the genes selected for screening. Variants detected in flanking intronic regions were largely 
uninterpretable. Intronic regions are more variable than coding regions, thus more variants are 
detected in those regions, but population frequency data is less readily available. Thus a 
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causative variant would be more difficult to discern from the many benign variants in non-
coding regions. Intronic and non-genic variants are supposed, probably correctly, to be more 
numerous because they have no functional effect on the gene product, and thus are not under 
selective pressure. However, some number of these variants certainly occur in regions with 
regulatory function. The difficulty is in discerning which are which. Regulatory elements may be 
located at some distance from the coding region of the gene, and lack the clear structure of an 
open reading frame, a start, and a stop, by which to identify them. Work done in model 
organisms, such as drosophila melanogaster, has clearly shown the importance of regulatory 
elements, but at this time it is difficult to extend this work to human studies in a meaningful 
way. 
 
This work identified the first locus with statistically significant linkage in MacTel families. When 
17 families with inherited MacTel were analyzed for linkage, all families displayed linkage to 
chromosome 1q41-42 with a significant lod score. When additional families were added to the 
analysis, heterogeneity was detected, indicating that there may be more than one causative 
locus for the disease. This was not an unexpected finding. Observing that two out of 23 families 
are not linked to the chromosome 1q41-42 locus, each family that does display linkage must be 
assessed for the possibility that linkage to the region could be by chance alone. Considering an 
affected sibling pair, it is expected that across 25% of the genome, the siblings will share two 
alleles identical by descent, across 50% 1 allele with be shared identical by descent, and across 
25% of the genome no alleles will be shared identical by descent. Given this expectation, 75% of 
the genome is consistent with inheritance of an autosomal dominant trait. Power is built up in 
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linkage studies by combining the findings from many families, or from identifying large families 
where the proportion of expected allele sharing is lower because of the complexity of the 
family structure. Extrapolating from the small number of families in this cohort, it is reasonable 
to estimate that 1 in 10 families does not carry a susceptibility allele in the 1q41-42 region. 
While this estimate is subject to sampling error given the small number of families, it is an 
indication that results from any single family may be spurious. 
 
FUTURE DIR ECTIONS  
 
This work has been carried out during a time of rapid change in the technology and methods 
available to individual labs for the study of human genetic disease. Due to the support of the 
MacTel Project, we have been able to apply very newly available technologies to the study of 
this disease. The linkage interval detected remains too large to sequence reasonably using 
Sanger sequencing. Narrowing the interval using methods available previously would require 
adding additional families to the linkage analysis, in the hopes of observing a recombination 
between the endpoints of the linkage interval and the true disease locus. The observation of 
heterogeneity in the cohort complicates this approach, because any such recombination would 
have to be interpreted in light of the conditional probability that linkage to the region in any 




Exome sequencing, in theory, could reveal a coding mutation, and filtering the results based on 
linkage and recombination mapping results adds additional power to such an approach. The 
inherent limitation of this approach is that non-coding variants will not be detected. Exome 
sequencing has been widely seen as an interim step in methodology. It became available at a 
time when genome sequencing was out of reach for individual labs. One advantage to exome 
sequencing is that it produces a smaller dataset, with more readily interpretable results. As 
whole genome sequencing becomes more readily available, the bioinformatics support 
necessary to interpret that data will need to keep pace. This is already proving to be a 
significant issue. In the case of this project, significant technological limitations of exome 
sequencing as a very new technology resulted in data that was insufficient to answer the 
research question. In the short time since, publications and personal communications indicate 
that groups still employing exome sequencing are taking these risks into account, demanding 
heavier sequencing coverage of the exome, and expanding the definition of the exome. 
 
Recently, our group sequenced the genome of one MacTel patient using the services of 
Complete Genomics. The data was compared to genotyping and Sanger sequencing results to 
determine that both the false positive and false negative rates were acceptably low. We have 
recently sequenced eight additional genomes from 7 families. Variants detected will be filtered 
as planned for exome sequencing, to query rare or unknown missense variants. These data will 
allow inspection of the entire linkage interval on chromosome 1. With the majority of families 
linked to this region, the hypothesis is that a causal variant would be shared identical by 
descent in affected relatives, and that the same or another variant will be present in unrelated 
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affected individuals. As sequencing costs continue to fall rapidly, additional genomes may be 
reasonably sequenced, adding additional power to detect a true causal variant.  
 
This is the first time in history that large scale sequencing has been available to individual labs 
to investigate a disease in this manner. This work has been performed at a time when many 
groups are searching for the best ways to apply these newly available methods to detect 
functional variants in the genome. This work has drawn on both traditional and very new 
methods, in new combinations, to attempt to determine the genetic cause of a disease that has 
not been previously studied for a potential genetic cause.  
 
This work represents my effort, and the efforts of many collaborators, to identify a cause for 
MacTel. These efforts are ongoing, in the hope that identifying a genetic cause would provide 
guidance for further research, and potentially identify targets for treatment to improve the 











In the previous analyses, we had assumed an autosomal dominant mode of inheritance for 
MacTel, and that no cases in our sample were caused by non-genetic factors. Only affected and 
possibly affected individuals were analyzed to prevent potentially declaring non-penetrant risk 
allele carriers as unaffected. This approach had the drawback of discarding genetic information 
from the unaffected individuals. Here we explore the effects of some different assumption on 
the linkage results, testing dominant versus recessive models under three prevalence values 
and three penetrance values, allowing for a small proportion of sporadic (non-genetic) cases. 
We also use all individuals in the families, both affected and unaffected. The goal of these 
analyses was to recover information from the unaffecteds that was not utilized in the previous 
analyses. Additionally, model misspecification can result in linkage scores that are diminished as 
compared to the scores that would be observed under a true model, which is to say a model 
that is consistent with the actual values for mode of inheritance, risk allele frequency, 
penetrance, and phenocopy rate for the disease (Hodge and Elston, 1994). While the true 
values for these parameters are unknown, this kind of analysis can reveal something about the 
true mode of inheritance and associated parameters by maximizing over models (Hodge and 






The total population prevalence of a disease is the sum of the prevalence due to genetic 
reasons and the prevalence due to non-genetic reasons (phenocopies).  We assume that the 
majority of MacTel cases are genetic, and a small percentage (1%) are non-genetic. By assuming 
values for total population prevalence and further assuming that the allele (or alleles) 
responsible are in Hardy Weinberg equilibrium, that is, not subject to selective pressure (a 
reasonable assumption for a late-onset disease), we can calculate the allele frequencies that 
would lead to a given population prevalence. Additionally, we assume reduced penetrance, 
which is to say that not every individual carrying a risk allele will express the MacTel phenotype. 
This analysis tests population prevalence values of 0.001, 0.002, and 0.005, and penetrance 
values of 20%, 50%, and 80%. 
 
We use G to represent the at-risk genotype.  In other words, for a dominant disease, where A is 
the risk allele, and a is the non-risk allele, G = AA or Aa. For a recessive disease where a 
represents the risk allele, G = aa. Let K represent the population prevalence. Let f represent the 
penetrance, where penetrance is defined as the probability of being affected given that at 
individual has a risk genotype. This can be written as P(affected | G). Let g represent the 
phenocopy frequency, defined as the probability of having the disease given that an individual 
does not have an at-risk genotype. This can be written as P(affected | not G). Then, the total 
population prevalence can be expressed as the sum of the proportion of individuals in the 
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population with the at-risk genotype multiplied by the probability they will express the trait, 
plus the proportion of individuals in the population with the non-risk genotype multiplied by 
the probability they will express the trait for non-genetic reasons. 
 
])[1(][][][ GPgGfPGnotPgGPfK  
 
The prevalence due to genetic and non-genetic causes can also be expressed graphically, as in 
Figure 1. 
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Figure 1.  Visual representation of proportions of affected and unaffected people in a 
hypothetical population.  The narrow left bar represents proportion of the at-risk genotype G in 
the population, & the broad right section of the graph represents the proportion of the 




For a single biallelic locus, where p is the risk allele and q is the non-risk allele, the sum of the 
two allele frequencies in the population must add up to 1. This is expressed as p + q = 1. The 
sum of the genotype frequencies must also add up to 1. This is expressed as p2 + 2pq + q2 = 1. 
From this, we can express the proportion of genetic cases in terms of allele frequencies. 
 
models recessivefor  







Referring to figure 1, within the G, section the proportion f is affected (shaded in), & the 
proportion f1  is unaffected.  Similarly, within the not-G section, the proportion g is affected. 
The total shaded area represents K, the population prevalence.  From the diagram, we can see 
that K must equal  
 
 ])[1(][][][ GPgGfPGnotPgGPfK . (1) 
 
We can also see that the proportion of K due to nongenetic causes, , must equal the shaded 
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From these equations, substitute eq. (b) into the rightmost term of eq. (a), to get 
KGfPK ][ .  Subtract K from both sides to get ][)1( GPfKKK . Then 






][ . (2) 
Another way to think of eq. (2) is this:  Of the total shaded area in the figure (which represents 
population prevalence K), the proportion that’s genetic is K)1( .  If penetrance were 100%, 
then that proportion would also exactly equal the proportion of the at-risk genotype in the 
population.  But in our model, the proportion of the at-risk genotype must be greater, so that 
when we multiply by the reduced penetrance, we’ll get the right population proportion of 
affected people with the genetic form. 
 





From these relationships, we can solve for the risk allele frequencies under any assumed values 
for K and g. 
Dominant 
From eq. (1), ][12 GPq , so q is the square root of that, & then subtract from unity to get p: 




From eq. (1), ][2 GPp , so 
 ][GPp . 
 
Table 1 gives the calculated values assuming populations prevalences of 1/10,000, 1/5,000, and 
1/2,000, assuming penetrance values of 20%, 50%, and 80% for each assumed prevalence, with 
the assumption that non-genetic cases account for 1% of total prevalence. 




 ( f) 
Phenocopy 
rate (g) 





.0001 0.20 1.0005 x 10-6 4.950 x 10-4 2.475 x 10-4 0.0222 
 0.50 1.0002 x 10-6 1.980 x 10-4 9.900 x 10-5 0.0140 
 0.80 1.0001 x 10-6 1.238 x 10-4 6.188 x 10-5 0.0111 
.0002 0.20 2.0020 x 10-6 9.900 x 10-4 4.951 x 10-4 0.0314 
 0.50 2.0008 x 10-6 3.960 x 10-4 1.980 x 10-4 0.0198 
 0.80 2.0005 x 10-6 2.475 x 10-4 1.238 x 10-4 0.0157 
.0005 0.20 5.0124 x 10-6 2.475 x 10-3 1.238 x 10-3 0.0497 
 0.50 5.0050 x 10-6 9.900 x 10-4 4.951 x 10-4 0.0314 
 0.80 5.0031 x 10-6 6.188 x 10-4 3.094 x 10-4 0.0248 
Table 1. Calculated values for phenocopy rate, population prevalence of at-risk genotypes, and 
allele frequencies for dominant and recessive models under assumed values for total disease 





Consistent with results from previous analyses, multipoint parametric linkage analysis using the 
models listed in Table 1 resulted in a maximum LOD score at chromosome 1q41, under all 
dominant models (Figure 2.). The maximum LOD score of 3.83 (HLOD = 3.86, alpha = .96) was 
observed under the assumption of 1/5000 prevalence with 20% penetrance.  The maximum 
HLOD was observed at the same marker, under the same model. For all prevalence values, the 
maximum score was observed under the model of 20% penetrance. No evidence for linkage 
was observed under any recessive model. One additional region of slightly positive linkage was 
observed on chromosome 9 (LOD = .42, HLOD = 1.6, alpha = .68) at approximately 9 cM under a 
model of 1/5000 prevalence and 20% penetrance (Figure 3). This region yielded a slightly 
positive LOD score in previous analyses. All other regions across the genome yielded negative 





Figure 2. The maximum LOD score observed under all models occurred at chromosome 1q41, 




These analyses resulted in a maximum LOD score observed at the same position on 
chromosome 1 as observed in previous tests for linkage. The maximum LOD score increased 
slightly as compared to previous tests when unaffected family members were included in the 
analysis and reduced penetrance was modeled. The calculated risk allele frequency under the 
model that yielded the highest LOD score in these tests was 0.0012383; the risk allele frequency 
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assumed in previous tests was 0.001. This result suggests that MacTel is subject to reduced 
penetrance, and that there is evidence under additional models for linkage at the region of 
previous interest at chromosome 1q41. From these analyses, we observed that there is 
statistical evidence favoring an autosomal dominant mode of inheritance for MacTel. 
 
This work represents an approach to analyze a collection of families for linkage when the mode 
of inheritance, population prevalence, penetrance, and phenocopy rates are unknown. One 
advantages of the method used here over the approaches described in previous chapters is that 
the information from unaffected individuals in the sample is utilized. Additionally, the risk of 
missing true linkage due to model misspecification is mitigated. When the population 
parameters of a disease are unknown, as is often the case, one approach is to choose a set of 
parameters arbitrarily, accepting that the resulting LOD score may be reduced as compared to 
what would be observed under parameters that better approximate the true population values, 
but that linkage may be observed nonetheless. The effects of model parameter assumptions on 
linkage analysis were described by Hodge and Elston (Hodge and Elston, 1994). An alternate 
approach is to maximize over models, on the premise that model misspecification reduces the 
resulting LOD score, and that the power to detect true linkage is increased by evaluating a 
range of parameters. The validity of this method was shown in simulation studies (Greenberg et 
al., 1998; Abreu et al., 1999). 
These analyses provided statistical evidence for reduced penetrance in MacTel, which had long 
been presumed, but had not been shown. In previous analysis, it was shown that when the 
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sample was analyzed using all individuals, with unaffected individuals declared as such, the 
linkage signal on chromosome 1 was greatly reduced under a penetrance value of 0.9. That 
result suggested that unaffected individuals in the sample  do carry genotypes compatible with 
linkage in the region of interest. Declaring such individuals to be unaffected reduced the 
evidence for linkage in the region. While it is formally possible that there is in fact no true 
disease causing allele in the region, that analysis failed to evaluate the alternate hypothesis that 
the MacTel phenotype does not manifest uniformly or completely in every individual who 
carries a putative risk allele (or alleles). This is a reasonable and necessary hypothesis to 
evaluate, given that complete penetrance is likely the exception rather than the rule in 
inherited disease, and given the fact that variable expressivity has been observed for this 
disease.  
 
The additional contribution of these analyses beyond the results presented in previous chapters 
is to present statistical evidence for an autosomal dominant mode of inheritance in the absence 
of formal segregation analysis, and to present evidence for reduced penetrance in the families 
analyzed. It is encouraging that the results observed and presented here are consistent with 
previous observations, bolstering the hypothesis that a true risk allele for MacTel may exist in 
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